CA2441603A1 - Apparatus and method for sequencing a nucleic acid - Google Patents
Apparatus and method for sequencing a nucleic acid Download PDFInfo
- Publication number
- CA2441603A1 CA2441603A1 CA002441603A CA2441603A CA2441603A1 CA 2441603 A1 CA2441603 A1 CA 2441603A1 CA 002441603 A CA002441603 A CA 002441603A CA 2441603 A CA2441603 A CA 2441603A CA 2441603 A1 CA2441603 A1 CA 2441603A1
- Authority
- CA
- Canada
- Prior art keywords
- array
- nucleic acid
- reaction
- cavity
- reaction chamber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/62—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light
- G01N21/63—Systems in which the material investigated is excited whereby it emits light or causes a change in wavelength of the incident light optically excited
- G01N21/64—Fluorescence; Phosphorescence
- G01N21/645—Specially adapted constructive features of fluorimeters
- G01N21/6452—Individual samples arranged in a regular 2D-array, e.g. multiwell plates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L3/00—Containers or dishes for laboratory use, e.g. laboratory glassware; Droppers
- B01L3/50—Containers for the purpose of retaining a material to be analysed, e.g. test tubes
- B01L3/502—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures
- B01L3/5027—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip
- B01L3/502715—Containers for the purpose of retaining a material to be analysed, e.g. test tubes with fluid transport, e.g. in multi-compartment structures by integrated microfluidic structures, i.e. dimensions of channels and chambers are such that surface tension forces are important, e.g. lab-on-a-chip characterised by interfacing components, e.g. fluidic, electrical, optical or mechanical interfaces
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
- C12P19/28—N-glycosides
- C12P19/30—Nucleotides
- C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6869—Methods for sequencing
- C12Q1/6874—Methods for sequencing involving nucleic acid arrays, e.g. sequencing by hybridisation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/01—Arrangements or apparatus for facilitating the optical investigation
- G01N21/03—Cuvette constructions
- G01N21/0303—Optical path conditioning in cuvettes, e.g. windows; adapted optical elements or systems; path modifying or adjustment
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
- G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
- G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
- G01N21/7703—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator using reagent-clad optical fibres or optical waveguides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0636—Integrated biosensor, microarrays
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/06—Auxiliary integrated devices, integrated components
- B01L2300/0627—Sensor or part of a sensor is integrated
- B01L2300/0654—Lenses; Optical fibres
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0816—Cards, e.g. flat sample carriers usually with flow in two horizontal directions
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0819—Microarrays; Biochips
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0809—Geometry, shape and general structure rectangular shaped
- B01L2300/0822—Slides
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0861—Configuration of multiple channels and/or chambers in a single devices
- B01L2300/0877—Flow chambers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L2300/00—Additional constructional details
- B01L2300/08—Geometry, shape and general structure
- B01L2300/0893—Geometry, shape and general structure having a very large number of wells, microfabricated wells
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01L—CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B01L9/00—Supporting devices; Holding devices
- B01L9/52—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips
- B01L9/527—Supports specially adapted for flat sample carriers, e.g. for plates, slides, chips for microfluidic devices, e.g. used for lab-on-a-chip
Abstract
Disclosed herein are methods and apparatus for sequencing a nucleic acid. These methods permit a very large number of independent sequencing reactions to be arrayed in parallel, permitting simultaneous sequencing of a very larg e number (>10,000) of different oligonucleotides.
Claims (181)
1. An array comprising a planar surface with a plurality of reaction chambers disposed thereon, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm and each chamber has a width in at least one dimension of between 0.3 µm and 100 µm.
2. An array comprising a planar surface with a plurality of cavities thereon, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm and each cavity has a width in at least one dimension of between 0.3µm and 100 µm.
3. An array comprising a planar surface with a plurality of cavities thereon, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm and.each reaction chamber has no more than one single stranded circular nucleic acid disposed therein.
4. The array of claim 3 wherein each single stranded circular nucleic acid contains at least 100 copies of a nucleic acid sequence, each copy covalently linked end to end.
5. The array of claim 3 wherein the single stranded circular nucleic acid is immobilized in the reaction chamber.
6. The array of claim 5 wherein the single stranded circular nucleic acid is immobilized on a mobile solid support disposed in the reaction chamber.
7. The array of claim 3, wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 100 µm.
8. The array of claim 3, wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 20 µm.
9. The array of claim 3, wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 10 µm.
10. The array of claim 3, wherein each reaction chamber has a width in at least one dimension of between 20 µm and 70 µm.
11. The array of claim 3, wherein the cavities number greater than 400,000.
12. The array of claim 3, wherein the cavities number between 400,000 and 20,000,000.
13. The array of claim 3, wherein the cavities number between 1,000,000 and 16,000,000.
14. The array of claim 3, wherein the shape of each cavity is substantially hexagonal.
15. The array of claim 3 wherein the center to center spacing is between 10 to 150 µm.
16. The array of claim 3 wherein the center to center spacing is between 50 to 100 µm.
17. The array of claim 3, wherein each cavity has a depth of between 10 µm and 100 µm.
18. The array of claim 3, wherein each cavity has a depth that is between 0.25 and times the size of the width of the cavity.
19. The array of claim 3, wherein each cavity has a depth that is between 0.3 and 1 times the size of the width of the cavity.
20. An array comprising a planar top surface and a planar bottom surface wherein the planar top surface has at least 1,000 cavities thereon, each cavity forming an analyte reaction chamber, the planar bottom surface is optically conductive such that optical signals from the reaction chambers can be detected through the bottom planar surface, wherein the distance between the top surface and the bottom surface is no greater than 10 cm, wherein the reaction chambers have a center to center spacing of between 5 to 200µm and each chamber having a width in at least one dimension of between 0.3µm and 100µm.
21. The array of claim 20 wherein the center to center spacing is between 10 to 150 µm.
22. The array of claim 20 wherein the center to center spacing is between 50 to 100 µm.
23. The array of claim 20, wherein the cavities number greater than 400,000.
24. The array of claim 20, wherein the cavities number between 400,000 and 20,000,000.
25. The array of claim 20, wherein the cavities number between 1,000,000 and 16,000,000.
26. The array of claim 20, wherein the shape of each cavity is substantially hexagonal.
27. The array of claim 20, wherein each cavity has a width in at least one dimension of between 0.3 µm and 10 µm.
28. The array of claim 20, wherein each cavity has a width in at least one dimension of between 0.3 µm and 20 µm.
29. The array of claim 20, wherein each cavity has a width in at least one dimension of between 20 µm and 70 µm.
30. The array of claim 20, wherein each cavity has a depth of between 10 µm and 100 µm.
31. The array of claim 20, wherein each cavity has a depth that is between 0.25 and 5 times the size of the width of the cavity.
32. The array of claim 20, wherein each cavity has a depth that is between 0.3 and 1 times the size of the width of the cavity.
33. The array of claim 20, wherein each cavity has at least one irregular wall surface.
34. The array of claim 20, wherein each cavity has a smooth wall surface.
35. The array of claim 20, wherein the cavities are formed from a fiber optic bundle.
36. The array of claim 35, wherein the cavities are formed by etching one end of the fiber optic bundle.
37. The array of claim 20, wherein each cavity contains reagents for analyzing a nucleic acid or protein.
38. The array of claim 20 further comprising a second surface spaced apart from the planar array and in opposing contact therewith such that a flow chamber is formed over the array.
39. An array means for carrying out separate parallel common reactions in an aqueous environment, wherein the array means comprises a substrate comprising at least 1,000 discrete reaction chambers containing a starting material that is capable of reacting with a reagent, each of the reaction chambers being dimensioned such that when one or more fluids containing at least one reagent is delivered into each reaction chamber, the diffusion time for the reagent to diffuse out of the well exceeds the time required for the starting material to react with the reagent to form a product.
40. The array of claim 39 wherein the reaction chambers are formed by generating a plurality of cavities on the substrate.
41. The array of claim 39 wherein the reaction chambers are formed by generating discrete patches on a planar surface, said patches having a different surface chemistry than the surrounding planar surface.
42. The array of claims 39 or 41, wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 100 µm.
43. The array of claims 39 or 41, wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 20 µm.
44. The array of claims 39 or 41, wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 10 µm.
45. The array of claims 39 or 41, wherein each reaction chamber has a width in at least one dimension of between 20 µm and 70 µm.
46. The array of claims 39 or 41 wherein the center to center spacing is between 5 to 200µm.
47. The array of claims 39 or 41 wherein the center to center spacing is between 10 to 150 µm.
48. The array of claims 39 or 41 wherein the center to center spacing is between 50 to 100 µm.
49. The array of claims 39 or 41, wherein the cavities number greater than 400,000.
50. The array of claims 39 or 41, wherein the cavities number between 400,000 and 20,000,000.
51. The array of claims 39 or 41, wherein the cavities number bet>veen 1,000,000 and 16,000,000.
52. The array of claims 39 or 41, wherein the shape of each cavity is substantially hexagonal.
53. The array of claims 39 or 41, wherein each cavity has a depth of between µm and 100 µm.
54. The array of claims 39 or 41, wherein each cavity has a depth that is between 0.25 and 5 times the size of the width of the cavity.
55. The array of claims 39 or 41, wherein each cavity has a depth that is between 0.3 and 1 times the size of the width of the cavity.
56. The array of claims 39 or 41, wherein each cavity has at least one irregular wall surface.
57. The array of claims 39 or 41, wherein each cavity has a smooth wall surface.
58. The array of claims 39 or 41, wherein the cavities are formed from a fiber optic bundle.
59. The array of claim 58, wherein the cavities are formed by etching one end of the fiber optic bundle.
60. The array of claims 39 or 41, wherein each cavity contains reagents for analyzing a nucleic acid or protein.
61. The array of claims 39 or 41 further comprising a population of mobile solid supports disposed in the reaction chambers, each mobile solid support having one or more bioactive agents attached thereto.
62. The array of claim 40, wherein the cavities are formed in the substrate via etching, molding or micromaching.
63. The array of claim 40, wherein the substrate is a fiber optic bundle.
64. The array of claim 40, wherein the cavities are cylindrical.
65. The array of claim 40, wherein the bottom of each of the cavities is planar.
66. The array of claim 40, wherein the bottom of each of the cavities is concave.
67. An array comprising a planar surface with a plurality of reaction chambers disposed thereon, wherein the reaction chambers have a center to center spacing of between 5 to 200µm and each chamber has a width in at least one dimension of between 0.3µm and 100µm wherein at least one reaction chamber has a mobile solid support having at least one reagent immobilized thereon, wherein the reagent is suitable for use in a nucleic acid sequencing reaction.
68. The array of claim 67, wherein the diameter of each mobile solid support is between 0.01 to 0.1 times the width of each cavity.
69. The array of claim 67, wherein at least 5% to 20% of the reaction chambers have a mobile solid support having at least one reagent immobilized thereon.
70. The array of claim 67, wherein at least 20% to 60% of the reaction chambers have a mobile solid support having at least one reagent immobilized thereon.
71. The array of claim 67, wherein at least 50% to 100% of the reaction chambers have a mobile solid support having at least one reagent immobilized thereon.
72. The array of claim 67, wherein the mobile solid support has at least one reagent immobilized thereon, wherein the reagent is a polypeptide with sulfurylase activity.
73. The array of claim 67, wherein the mobile solid support has at least one reagent immobilized thereon, wherein the reagent is a polypeptide with luciferase activity.
74. The array of claim 67, wherein the mobile solid support has at least one reagent immobilized thereon, wherein the reagent is a chimeric polypeptide having both sulfurylase and luciferase activity.
75. The array of claim 67, wherein the mobile solid support has at least a first reagent and a second reagent immobilized thereon, wherein the first reagent is a polypeptide with sulfurylase activity, and the second reagent is a polypeptide with luciferase activity.
76. The array of claim 67 wherein the center to center spacing is between 10 to 150 µm.
77. The array of claim 67 wherein the center to center spacing is between 50 to 100 µm.
78. The array of claim 67, wherein the cavities number greater than 400,000.
79. The array of claim 67, wherein the cavities number between 400,000 and 20,000,000.
80. The array of claim 67, wherein the cavities number between 1,000,000 and 16,000,000.
81. The array of claim 67, wherein the shape of each cavity is substantially hexagonal.
82. The array of claim 67, wherein each cavity has a width in at least one dimension of between 0.3 µm and 10 µm.
83. The array of claim 67, wherein each cavity has a width in at least one dimension of between 0.3 µm and 20 µm.
84. The array of claim 67, wherein each cavity has a width in at least one dimension of between 20 µm and 70 µm.
85. The array of claim 67, wherein each cavity has a depth of between 10 µm and 100 µm.
86. The array of claim 67, wherein each cavity has a depth that is between 0.25 and 5 times the size of the width of the cavity.
87. The array of claim 67, wherein each cavity has a depth that is between 0.3 and 1 times the size of the width of the cavity.
88. An array comprising a planar surface with a plurality of reaction chambers disposed thereon, wherein the reaction chambers have a center to center spacing of between 5 to 200µm and each chamber has a width in at least one dimension of between 0.3µm and 100µm wherein at least one reaction chamber has a mobile solid support having at least one reagent immobilized thereon, wherein the reagent(s) is a nucleic acid, said nucleic acid comprising a single stranded concatamer.
89. The array of claim 88, wherein the nucleic acid is suitable for use in a pyrosequencing reaction.
90. The method of using the mobile solid support of claim 67 to detect ATP
activity.
activity.
91. The method of claim 90, wherein the ATP is detected as part of a nucleic acid sequencing reaction.
92. The array of claim 88, wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 20 µm.
93. The array of claim 88, wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 10 µm.
94. The array of claim 88, wherein each reaction chamber has a width in at least one dimension of between 20 µm and 70 µm.
95. The array of claim 88, wherein the cavities number greater than 400,000.
96. The array of claim 88, wherein the cavities number between 400,000 and 20,000,000.
97. The array of claim 88, wherein the cavities number between 1,000,000 and 16,000,000.
98. The array of claim 88 wherein the center to center spacing is between 10 to 150 µm.
99. The array of claim 88 wherein the center to center spacing is between 50 to 100 µm.
100. The array of claim 88, wherein each cavity has a depth of between 10 µm and 100 µm.
101. The array of claim 88, wherein each cavity has a depth that is between 0.25 and 5 times the size of the width of the cavity.
102. The array of claim 88, wherein each cavity has a depth that is between 0.3 and 1 times the size of the width of the cavity.
103. A method for delivering a bioactive agent to an array, comprising dispersing over the array a plurality of mobile solid supports, each mobile solid support having at least one reagent immobilized thereon, wherein the reagent is suitable for use in a nucleic acid sequencing reaction, where the array comprises a planar surface with a plurality of reaction chambers disposed thereon, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm and each chamber has a width in at least one dimension of between 0.3 µm and 100 µm.
104. An apparatus for simultaneously monitoring an array of reaction chambers for light indicating that a reaction is taking place at a particular site, the apparatus comprising:
(a) an array of reaction chambers formed from a planar substrate comprising a plurality of cavitated surfaces, each cavitated surface forming a reaction chamber adapted to contain analytes, and wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, the array comprising more than 400,000 discrete reaction chambers;
(b) an optically sensitive device arranged so that in use the light from a particular reaction chamber will impinge upon a particular predetermined region of said optically sensitive device;
(c) means for determining the light level impinging upon each of said predetermined regions and (d) means to record the variation of said light level with time for each of said reaction chamber.
(a) an array of reaction chambers formed from a planar substrate comprising a plurality of cavitated surfaces, each cavitated surface forming a reaction chamber adapted to contain analytes, and wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, the array comprising more than 400,000 discrete reaction chambers;
(b) an optically sensitive device arranged so that in use the light from a particular reaction chamber will impinge upon a particular predetermined region of said optically sensitive device;
(c) means for determining the light level impinging upon each of said predetermined regions and (d) means to record the variation of said light level with time for each of said reaction chamber.
105. An analytic sensor, comprising:
(a) an array formed from a first bundle of optical fibers with a plurality of cavitated surfaces at one end thereof, each cavitated surface forming a reaction chamber adapted to contain analytes, and wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, the array comprising more than 400,000 discrete reaction chambers;
(b) an enzymatic or fluorescent means for generating light in the reaction chambers;
(c) light detection means comprising a light capture means and a second fiber optic bundle for transmitting light to the light detecting means, the second fiber optic bundle being in optical contact with the array, such that light generated in an individual reaction chamber is captured by a separate fiber or groups of separate fibers of the second fiber optic bundle for transmission to the light capture means.
(a) an array formed from a first bundle of optical fibers with a plurality of cavitated surfaces at one end thereof, each cavitated surface forming a reaction chamber adapted to contain analytes, and wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, the array comprising more than 400,000 discrete reaction chambers;
(b) an enzymatic or fluorescent means for generating light in the reaction chambers;
(c) light detection means comprising a light capture means and a second fiber optic bundle for transmitting light to the light detecting means, the second fiber optic bundle being in optical contact with the array, such that light generated in an individual reaction chamber is captured by a separate fiber or groups of separate fibers of the second fiber optic bundle for transmission to the light capture means.
106. The sensor of claim 105, wherein said sensor is suitable for use in a biochemical assay.
107. The sensor of claim 105, wherein said sensor is suitable for use in a cell-based assay.
108. The sensor of claim 105, wherein the light capture means is a CCD camera.
109. The sensor of claim 105, wherein the reaction chambers contain one or more mobile solid supports with a bioactive agent immobilized thereon.
110. A composition comprising a plurality of optical fibers in an fused optical fiber array with a plurality of cavitated surfaces at one end thereof, each cavitated surface forming a reaction chamber adapted to contain analytes, and wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, the array comprising more than 400,000 discrete reaction chambers, each reaction chamber containing one or more mobile solid supports, wherein the diameter of the mobile solid supports is between 0.01 to 0.1 times the width of each reaction chamber.
111. A method for carrying out separate parallel common reactions in an aqueous environment, comprising:
(a) delivering a fluid containing at least one reagent to an array, wherein the array comprises a substrate comprising at least 400,000 discrete reaction chambers containing a starting material that is capable of reacting with the reagent, each of the reaction chambers being dimensioned such that when the fluid is delivered into each reaction chamber, the diffusion time for the reagent to diffuse out of the well exceeds the time required for the starting material to react with the reagent to form a product; and (b) washing the fluid from the array in the time period (i) after the starting material has reacted with the reagent to form a product in each reaction chamber but (ii) before the reagent delivered to any one reaction chamber has diffused out of that reaction chamber into any other reaction chamber.
(a) delivering a fluid containing at least one reagent to an array, wherein the array comprises a substrate comprising at least 400,000 discrete reaction chambers containing a starting material that is capable of reacting with the reagent, each of the reaction chambers being dimensioned such that when the fluid is delivered into each reaction chamber, the diffusion time for the reagent to diffuse out of the well exceeds the time required for the starting material to react with the reagent to form a product; and (b) washing the fluid from the array in the time period (i) after the starting material has reacted with the reagent to form a product in each reaction chamber but (ii) before the reagent delivered to any one reaction chamber has diffused out of that reaction chamber into any other reaction chamber.
112. The method of claim 111 wherein the product formed in any one reaction chamber is independent of the product formed in any other reaction chamber, but is generated using one or more common reagents.
113. The method of claim 111 wherein the starting material is a nucleic acid sequence and at least one reagent in the fluid is a nucleotide or nucleotide analog.
114. The method of claim 113 wherein the fluid additionally comprises a polymerase capable of reacting the nucleic acid sequence and the nucleotide or nucleotide analog.
115. The method of claim 111 additionally comprising repeating steps (a) and (b) sequentially.
116. A method for delivering nucleic acid sequencing enzymes to an array, said array having a planar surface with a plurality of cavities thereon, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm; the method comprising dispersing over the array a plurality of mobile solid supports having one or more nucleic acid sequencing enzymes immobilized thereon, such that at least one mobile solid support is contained within each reaction chamber.
117. The method of claim 116 wherein one of the nucleic acid sequencing enzymes is a polypeptide with sulfurylase activity.
118. The method of claim 116 wherein one of the nucleic acid sequencing enzymes is a polypeptide with luciferase activity.
119. The method of claim 116 wherein one of the nucleic acid sequencing enzymes is a polypeptide with both sulfurylase and luciferase activity.
120. The method of claim 116 wherein the plurality of mobile solid supports include mobile solid supports having either a polypeptide with sulfurylase activity immobilized thereon or a polypeptide with luciferase activity immobilized thereon, or both a polypeptide with sulfurylase activity immobilized thereon and a polypeptide with luciferase activity immobilized thereon.
121. A method for delivering a nucleic acid sequence to an array, said array having a planar surface with a plurality of cavities thereon, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm; the method comprising dispersing over the array a plurality of mobile solid supports having one or more nucleic sequences immobilized thereon.
122. The method of claim 121 wherein the nucleic acid sequence is a single stranded circular nucleic acid.
123. The method of claim 122 wherein each single stranded circular nucleic acid contains at least 100 copies of a nucleic acid sequence, each copy covalently linked end to end.
124. A method for delivering a nucleic acid sequence to an array, said array having a planar surface with a plurality of cavities thereon, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm; the method comprising immobilizing within each cavity no more than one nucleic acid sequence.
125. The method of claim 124 wherein the nucleic acid sequence is a single stranded circular nucleic acid.
126. The method of claim 124 wherein each single stranded circular nucleic acid contains at least 100 copies of a nucleic acid sequence, each copy covalently linked end to end.
127. The method of any one of claims 116-126 wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 100 µm.
128. The method of any one of claims 116-126 wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 20 µm.
129. The method of any one of claims 116-126 wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 10 µm.
130. The method of any one of claims 116-126 wherein each reaction chamber has a width in at least one dimension of between 20 µm and 70 µm.
131. The method of any one of claims 116-126 wherein the cavities number greater than 400,000.
132. The method of any one of claims 116-126 wherein the cavities number between 400,000 and 20,000,000.
133. The method of any one of claims 116-126 wherein the cavities number between 1,000,000 and 16,000,000.
134. The method of any one of claims 116-126 wherein the center to center spacing is between 10 to 150 µm.
135. The method of any one of claims 116-126 wherein the center to center spacing is between 50 to 100 µm.
136. The method of any one of claims 116-126, wherein each cavity has a depth of between 10 µm and 100 µm.
137. The method of any one of claims 116-126 wherein each cavity has a depth that is between 0.25 and 5 times the size of the width of the cavity.
138. The method of any one of claims 116-126 wherein each cavity has a depth that is between 0.3 and 1 times the size of the width of the cavity.
139. The method of claims 121 or 124 wherein the nucleic acid sequence is further amplified to produce multiple copies of said nucleic acid sequence after being disposed in the reaction chamber.
140. The method of claim 139 wherein the nucleic acid sequence is amplified using an amplification technology selected from the group consisting of polymerase chain reaction, ligase chain reaction and isothermal DNA amplification.
141. A method for sequencing a nucleic acid, the method comprising:
(a) providing one or more nucleic acid anchor primers;
(b) providing a plurality of single-stranded circular nucleic acid templates disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm;
(c) annealing an effective amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield a primed anchor primer-circular template complex;
(d) combining the primed anchor primer-circular template complex with a polymerase to form an extended anchor primer covalently linked to multiple copies of a nucleic acid complementary to the circular nucleic acid template;
(e) annealing an effective amount of a sequencing primer to one or more copies of said covalently linked complementary nucleic acid;
(f) extending the sequencing primer with a polymerase and a predetermined nucleotide triphosphate to yield a sequencing product and, if the predetermined nucleotide triphosphate is incorporated onto the 3' end of said sequencing primer, a sequencing reaction byproduct; and (g) identifying the sequencing reaction byproduct, thereby determining the sequence of the nucleic acid.
(a) providing one or more nucleic acid anchor primers;
(b) providing a plurality of single-stranded circular nucleic acid templates disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm;
(c) annealing an effective amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield a primed anchor primer-circular template complex;
(d) combining the primed anchor primer-circular template complex with a polymerase to form an extended anchor primer covalently linked to multiple copies of a nucleic acid complementary to the circular nucleic acid template;
(e) annealing an effective amount of a sequencing primer to one or more copies of said covalently linked complementary nucleic acid;
(f) extending the sequencing primer with a polymerase and a predetermined nucleotide triphosphate to yield a sequencing product and, if the predetermined nucleotide triphosphate is incorporated onto the 3' end of said sequencing primer, a sequencing reaction byproduct; and (g) identifying the sequencing reaction byproduct, thereby determining the sequence of the nucleic acid.
142. The method of claim 141 wherein each single stranded circular nucleic acid contains at least 100 copies of a nucleic acid sequence, each copy covalently linked end to end.
143. The method of claim 141 wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 100 µm.
144. The method of claim 141 wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 20 µm.
145. The method of claim 141 wherein each reaction chamber has a width in at least one dimension of between 0.3 µm and 10 µm.
146. The method of claim 141 wherein each reaction chamber has a width in at least one dimension of between 20 µm and 70 µm.
147. The method of claim 141 wherein the cavities number greater than 400,000.
148. The method of claim 141 wherein the cavities number between 400,000 and 20,000,000.
149. The method of claim 141 wherein the cavities number between 1,000,000 and 16,000,000.
150. The method of claim 141 wherein the center to center spacing is between 10 to 150 µm.
151. The method of claim 141 wherein the center to center spacing is between 50 to 100 µm.
152. The method of claim 141, wherein each cavity has a depth of between 10 µm and 100 µm.
153. The method of claim 141 wherein each cavity has a depth that is between 0.25 and 5 times the size of the width of the cavity.
154. The method of claim 141 wherein each cavity has a depth that is between 0.3 and 1 times the size of the width of the cavity.
155. The method of claim 141 wherein the nucleic acid sequence is further amplified to produce multiple copies of said nucleic acid sequence after being disposed in the reaction chamber.
156. The method of claim 155 wherein the nucleic acid sequence is amplified using an amplification technology selected from the group consisting of polymerase chain reaction, ligase chain reaction and isothermal DNA amplification.
157. The method of claim 141 wherein the single stranded circular nucleic acid is immobilized in the reaction chamber.
158. The method of claim 141 wherein the single stranded circular nucleic acid is immobilized on one or more mobile solid supports disposed in the reaction chamber.
159. A method for sequencing a nucleic acid, the method comprising:
(a) providing at least one nucleic acid anchor primer;
(b) providing a plurality of single-stranded circular nucleic acid templates in an array having at least 400,000 discrete reaction sites;
(c) annealing a first amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield a primed anchor primer-circular template complex;
(d) combining the primed anchor primer-circular template complex with a polymerase to form an extended anchor primer covalently linked to multiple copies of a nucleic acid complementary to the circular nucleic acid template;
(e) annealing a second amount of a sequencing primer to one or more copies of the covalently linked complementary nucleic acid;
(f) extending the sequencing primer with a polymerase and a predetermined nucleotide triphosphate to yield a sequencing product and, when the predetermined nucleotide triphosphate is incorporated onto the 3' end of the sequencing primer, to yield a sequencing reaction byproduct; and (g) identifying the sequencing reaction byproduct, thereby determining the sequence of the nucleic acid at each reaction site that contains a nucleic acid template.
(a) providing at least one nucleic acid anchor primer;
(b) providing a plurality of single-stranded circular nucleic acid templates in an array having at least 400,000 discrete reaction sites;
(c) annealing a first amount of the nucleic acid anchor primer to at least one of the single-stranded circular templates to yield a primed anchor primer-circular template complex;
(d) combining the primed anchor primer-circular template complex with a polymerase to form an extended anchor primer covalently linked to multiple copies of a nucleic acid complementary to the circular nucleic acid template;
(e) annealing a second amount of a sequencing primer to one or more copies of the covalently linked complementary nucleic acid;
(f) extending the sequencing primer with a polymerase and a predetermined nucleotide triphosphate to yield a sequencing product and, when the predetermined nucleotide triphosphate is incorporated onto the 3' end of the sequencing primer, to yield a sequencing reaction byproduct; and (g) identifying the sequencing reaction byproduct, thereby determining the sequence of the nucleic acid at each reaction site that contains a nucleic acid template.
160. The method of claim 159, wherein the anchor primer is linked to a particle.
161. The method of claim 159, wherein the anchor primer is linked to the particle prior to formation of the extended anchor primer.
162. The method of claim 159, wherein the anchor primer is linked to the particle after formation of the extended anchor primer.
163. The method of claim 159, wherein the sequencing reaction byproduct is PPi and a coupled sulfurylase/luciferase reaction is used to generate light for detection.
164. The method of claim 159, wherein either or both of the sulfurylase and luciferase are immobilized on one or more mobile solid supports disposed at each reaction site.
165. A method of determining the base sequence of a plurality of nucleotides on an array, the method comprising:
(a) providing a plurality of sample DNAs, each disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, (b) adding an activated nucleotide 5'-triphosphate precursor of one known nitrogenous base to a reaction mixture in each reaction chamber, each reaction mixture comprising a template-directed nucleotide polymerase and a single-stranded polynucleotide template hybridized to a complementary oligonucleotide primer strand at least one nucleotide residue shorter than the templates to form at least one unpaired nucleotide residue in each template at the 3'-end of the primer strand, under reaction conditions which allow incorporation of the activated nucleoside 5'-triphosphate precursor onto the 3'-end of the primer strands, provided the nitrogenous base of the activated nucleoside 5'-triphosphate precursor is complementary to the nitrogenous base of the unpaired nucleotide residue of the templates;
(c) detecting whether or not the nucleoside 5'-triphosphate precursor was incorporated into the primer strands in which incorporation of the nucleoside 5'-triphosphate precursor indicates that the unpaired nucleotide residue of the template has a nitrogenous base composition that is complementary to that of the incorporated nucleoside 5'-triphosphate precursor; and (d) sequentially repeating steps (b) and (c), wherein each sequential repetition adds and, detects the incorporation of one type of activated nucleoside 5'-triphosphate precursor of known nitrogenous base composition; and (e) determining the base sequence of the unpaired nucleotide residues of the template in each reaction chamber from the sequence of incorporation of said nucleoside precursors.
(a) providing a plurality of sample DNAs, each disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, (b) adding an activated nucleotide 5'-triphosphate precursor of one known nitrogenous base to a reaction mixture in each reaction chamber, each reaction mixture comprising a template-directed nucleotide polymerase and a single-stranded polynucleotide template hybridized to a complementary oligonucleotide primer strand at least one nucleotide residue shorter than the templates to form at least one unpaired nucleotide residue in each template at the 3'-end of the primer strand, under reaction conditions which allow incorporation of the activated nucleoside 5'-triphosphate precursor onto the 3'-end of the primer strands, provided the nitrogenous base of the activated nucleoside 5'-triphosphate precursor is complementary to the nitrogenous base of the unpaired nucleotide residue of the templates;
(c) detecting whether or not the nucleoside 5'-triphosphate precursor was incorporated into the primer strands in which incorporation of the nucleoside 5'-triphosphate precursor indicates that the unpaired nucleotide residue of the template has a nitrogenous base composition that is complementary to that of the incorporated nucleoside 5'-triphosphate precursor; and (d) sequentially repeating steps (b) and (c), wherein each sequential repetition adds and, detects the incorporation of one type of activated nucleoside 5'-triphosphate precursor of known nitrogenous base composition; and (e) determining the base sequence of the unpaired nucleotide residues of the template in each reaction chamber from the sequence of incorporation of said nucleoside precursors.
166. A method for determining the nucleic acid sequence in a template nucleic acid polymer, comprising:
(a) introducing a plurality of template nucleic acid polymers into a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, each reaction chamber having a polymerization environment in which the nucleic acid polymer will act as a template polymer for the synthesis of a complementary nucleic acid polymer when nucleotides are added;
(b) successively providing to the polymerization environment a series of feedstocks, each feedstock comprising a nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the feedstock is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released;
(c) detecting the formation of inorganic pyrophosphate to determine the identify of each nucleotide in the complementary polymer and thus the sequence of the template polymer.
(a) introducing a plurality of template nucleic acid polymers into a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, each reaction chamber having a polymerization environment in which the nucleic acid polymer will act as a template polymer for the synthesis of a complementary nucleic acid polymer when nucleotides are added;
(b) successively providing to the polymerization environment a series of feedstocks, each feedstock comprising a nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the feedstock is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released;
(c) detecting the formation of inorganic pyrophosphate to determine the identify of each nucleotide in the complementary polymer and thus the sequence of the template polymer.
167. A method of identifying the base in a target position in a DNA sequence of sample DNA, wherein:
(a) sample DNA is disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, said DNA being rendered single stranded either before or after being disposed in the reaction chambers, (b) an extension primer is provided which hybridizes to said immobilized single-stranded DNA at a position immediately adjacent to said target position;
(c) said immobilized single-stranded DNA is subjected to a polymerase reaction in the presence of a predetermined nucleotide triphosphate, wherein if the predetermined nucleotide triphosphate is incorporated onto the 3' end of said sequencing primer then a sequencing reaction byproduct is formed; and (d) identifying the sequencing reaction byproduct, thereby determining the nucleotide complementary to the base at said target position.
(a) sample DNA is disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, said DNA being rendered single stranded either before or after being disposed in the reaction chambers, (b) an extension primer is provided which hybridizes to said immobilized single-stranded DNA at a position immediately adjacent to said target position;
(c) said immobilized single-stranded DNA is subjected to a polymerase reaction in the presence of a predetermined nucleotide triphosphate, wherein if the predetermined nucleotide triphosphate is incorporated onto the 3' end of said sequencing primer then a sequencing reaction byproduct is formed; and (d) identifying the sequencing reaction byproduct, thereby determining the nucleotide complementary to the base at said target position.
168. A method of identifying a base at a target position in a sample DNA
sequence comprising:
(a) providing sample DNA disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, said DNA being rendered single stranded either before or after being disposed in the reaction chambers (b) providing an extension primer which hybridizes to the sample DNA
immediately adjacent to the target position (c) subjecting the sample DNA sequence and the extension primer to a polymerase reaction in the presence of a nucleotide triphosphate whereby the nucleotide triphosphate will only become incorporated and release pyrophosphate (PPi) if it is complementary to the base in the target position, said nucleotide triphosphate being added either to separate aliquots of sample-primer mixture or successively to the same sample-primer mixture (d) detecting the release of PPi to indicate which nucleotide is incorporated.
sequence comprising:
(a) providing sample DNA disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, said DNA being rendered single stranded either before or after being disposed in the reaction chambers (b) providing an extension primer which hybridizes to the sample DNA
immediately adjacent to the target position (c) subjecting the sample DNA sequence and the extension primer to a polymerase reaction in the presence of a nucleotide triphosphate whereby the nucleotide triphosphate will only become incorporated and release pyrophosphate (PPi) if it is complementary to the base in the target position, said nucleotide triphosphate being added either to separate aliquots of sample-primer mixture or successively to the same sample-primer mixture (d) detecting the release of PPi to indicate which nucleotide is incorporated.
169. A method of identifying a base at a target position in a single-stranded sample DNA
sequence, the method comprising:
(a) providing an extension primer which hybridizes to sample DNA immediately adjacent to the target position, said sample DNA disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, said DNA
being rendered single stranded either before or after being disposed in the reaction chambers;
(b) subjecting the sample DNA and extension primer to a polymerase reaction in the presence of a predetermined deoxynucleotide or dideoxynucleotide whereby the deoxynucleotide or dideoxynucleotide will only become incorporated and release pyrophosphate (PPi) if it is complementary to the base in the target position, said predetermined deoxynucleotides or dideoxynucleotides being added either to separate aliquots of sample-primer mixture or successively to the same sample-primer mixture, (c) detecting any release of PPi enzymatically to indicate which deoxynucleotide or dideoxynucleotide is incorporated ;
characterized in that, the PPi-detection enzyme(s) are included in the polymerase reaction step and in that in place of deoxy- or dideoxy adenosine triphosphate (ATP) a dATP
or ddATP analogue is used which is capable of acting as a substrate for a polymerase but incapable of acting as a substrate for a said PPi~detection enzyme.
sequence, the method comprising:
(a) providing an extension primer which hybridizes to sample DNA immediately adjacent to the target position, said sample DNA disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, said DNA
being rendered single stranded either before or after being disposed in the reaction chambers;
(b) subjecting the sample DNA and extension primer to a polymerase reaction in the presence of a predetermined deoxynucleotide or dideoxynucleotide whereby the deoxynucleotide or dideoxynucleotide will only become incorporated and release pyrophosphate (PPi) if it is complementary to the base in the target position, said predetermined deoxynucleotides or dideoxynucleotides being added either to separate aliquots of sample-primer mixture or successively to the same sample-primer mixture, (c) detecting any release of PPi enzymatically to indicate which deoxynucleotide or dideoxynucleotide is incorporated ;
characterized in that, the PPi-detection enzyme(s) are included in the polymerase reaction step and in that in place of deoxy- or dideoxy adenosine triphosphate (ATP) a dATP
or ddATP analogue is used which is capable of acting as a substrate for a polymerase but incapable of acting as a substrate for a said PPi~detection enzyme.
170. An apparatus for analyzing a nucleic acid sequence, the apparatus comprising:
(a) a reagent delivery cuvette, wherein the cuvette includes an array comprising a planar surface with a plurality of cavities thereon, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, wherein the reagent delivery cuvette contains reagents for use in a sequencing reaction;
(b) a reagent delivery means in communication with the reagent delivery cuvette;
(c) an imaging system in communication with the reagent delivery chamber; and (d) a data collection system in communication with the imaging system.
(a) a reagent delivery cuvette, wherein the cuvette includes an array comprising a planar surface with a plurality of cavities thereon, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, wherein the reagent delivery cuvette contains reagents for use in a sequencing reaction;
(b) a reagent delivery means in communication with the reagent delivery cuvette;
(c) an imaging system in communication with the reagent delivery chamber; and (d) a data collection system in communication with the imaging system.
171. An apparatus for determining the base sequence of a plurality of nucleotides on an array, the apparatus comprising:
(a) a reagent cuvette containing a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm;
(b) reagent delivery means for adding an activated nucleotide 5'-triphosphate precursor of one known nitrogenous base to a reaction mixture in each reaction chamber, each reaction mixture comprising a template-directed nucleotide polymerase and a single-stranded polynucleotide template hybridized to a complementary oligonucleotide primer strand at least one nucleotide residue shorter than the templates to form at least one unpaired nucleotide residue in each template at the 3'-end of the primer strand, under reaction conditions which allow incorporation of the activated nucleoside 5'-triphosphate precursor onto the 3'-end of the primer strands, provided the nitrogenous base of the activated nucleoside 5'-triphosphate precursor is complementary to the nitrogenous base of the unpaired nucleotide residue of the templates;
(c) detection means for detecting whether or not the nucleoside 5'-triphosphate precursor was incorporated into the primer strands in which incorporation of the nucleoside 5'-triphosphate precursor indicates that the unpaired nucleotide residue of the template has a nitrogenous base composition that is complementary to that of the incorporated nucleoside 5'-triphosphate precursor; and (d) means for sequentially repeating steps (b) and (c), wherein each sequential repetition adds and, detects the incorporation of one type of activated nucleoside 5'-triphosphate precursor of known nitrogenous base composition; and (e) data processing means for determining the base sequence of the unpaired nucleotide residues of the template in each reaction chamber from the sequence of incorporation of said nucleoside precursors.
(a) a reagent cuvette containing a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm;
(b) reagent delivery means for adding an activated nucleotide 5'-triphosphate precursor of one known nitrogenous base to a reaction mixture in each reaction chamber, each reaction mixture comprising a template-directed nucleotide polymerase and a single-stranded polynucleotide template hybridized to a complementary oligonucleotide primer strand at least one nucleotide residue shorter than the templates to form at least one unpaired nucleotide residue in each template at the 3'-end of the primer strand, under reaction conditions which allow incorporation of the activated nucleoside 5'-triphosphate precursor onto the 3'-end of the primer strands, provided the nitrogenous base of the activated nucleoside 5'-triphosphate precursor is complementary to the nitrogenous base of the unpaired nucleotide residue of the templates;
(c) detection means for detecting whether or not the nucleoside 5'-triphosphate precursor was incorporated into the primer strands in which incorporation of the nucleoside 5'-triphosphate precursor indicates that the unpaired nucleotide residue of the template has a nitrogenous base composition that is complementary to that of the incorporated nucleoside 5'-triphosphate precursor; and (d) means for sequentially repeating steps (b) and (c), wherein each sequential repetition adds and, detects the incorporation of one type of activated nucleoside 5'-triphosphate precursor of known nitrogenous base composition; and (e) data processing means for determining the base sequence of the unpaired nucleotide residues of the template in each reaction chamber from the sequence of incorporation of said nucleoside precursors.
172. An apparatus for determining the nucleic acid sequence in a template nucleic acid polymer, comprising:
(a) an array comprising a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, (b) nucleic acid delivery means for introducing a template nucleic acid polymers into the reaction chambers;
(c) nucleic acid delivery means to deliver reagents to the reaction chambers to create a polymerization environment in which the nucleic acid polymers will act as a template polymers for the synthesis of complementary nucleic acid polymers when nucleotides are added;
(d) reagent delivery means for successively providing to the polymerization environment a series of feedstocks, each feedstock comprising a nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the feedstock is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released;
(e) detection means for detecting the formation of inorganic pyrophosphate enzymatically; and (f) data processing means to determine the identity of each nucleotide in the complementary polymers and thus the sequence of the template polymers.
(a) an array comprising a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, (b) nucleic acid delivery means for introducing a template nucleic acid polymers into the reaction chambers;
(c) nucleic acid delivery means to deliver reagents to the reaction chambers to create a polymerization environment in which the nucleic acid polymers will act as a template polymers for the synthesis of complementary nucleic acid polymers when nucleotides are added;
(d) reagent delivery means for successively providing to the polymerization environment a series of feedstocks, each feedstock comprising a nucleotide selected from among the nucleotides from which the complementary nucleic acid polymer will be formed, such that if the nucleotide in the feedstock is complementary to the next nucleotide in the template polymer to be sequenced said nucleotide will be incorporated into the complementary polymer and inorganic pyrophosphate will be released;
(e) detection means for detecting the formation of inorganic pyrophosphate enzymatically; and (f) data processing means to determine the identity of each nucleotide in the complementary polymers and thus the sequence of the template polymers.
173. An apparatus for processing a plurality of analytes, the apparatus comprising:
(a) a flow chamber having disposed therein a substrate comprising a plurality of cavitated surfaces, each cavitated surface forming a reaction chamber adapted to contain analytes, and wherein the reaction chambers have a center to center spacing of between 5 to 200 µm;
(b) fluid means for delivering processing reagents from one or more reservoirs to the flow chamber so that the analytes disposed therein are exposed to the reagents; and (c) detection means for detecting a sequence of optical signals from each of the reaction chambers, each optical signal of the sequence being indicative of an interaction between a processing reagent and the analyze disposed in the reaction chamber, wherein the detection means is in communication with the cavitated surfaces.
(a) a flow chamber having disposed therein a substrate comprising a plurality of cavitated surfaces, each cavitated surface forming a reaction chamber adapted to contain analytes, and wherein the reaction chambers have a center to center spacing of between 5 to 200 µm;
(b) fluid means for delivering processing reagents from one or more reservoirs to the flow chamber so that the analytes disposed therein are exposed to the reagents; and (c) detection means for detecting a sequence of optical signals from each of the reaction chambers, each optical signal of the sequence being indicative of an interaction between a processing reagent and the analyze disposed in the reaction chamber, wherein the detection means is in communication with the cavitated surfaces.
174. The apparatus of claim 173, wherein the detection means is a CCD camera.
175. The apparatus of claim 173, wherein the analyte is nucleic acid.
176. The apparatus of claim 173, wherein the analytes are immobilized on one or more mobile solid supports that are disposed in the reaction chamber.
177. The apparatus of claim 173 wherein the processing reagents are immobilized on one or more mobile solid supports.
178. An array comprising a planar surface with a plurality of cavities thereon, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, each cavity being formed such that the diffusion coefficient for any aqueous solution leaving the reaction chamber is 1.6667 x 10 -9 m2/s.
179. A method of determining the base sequence of a plurality of nucleotides on an array, the method comprising:
(a) providing a plurality of sample DNAs, each disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, (c) detecting the light level emitted from a plurality of reaction sites on respective portions of an optically sensitive device;
(d) converting the light impinging upon each of said portions of said optically sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions;
(e) determining a light intensity for each of said discrete regions from the corresponding electrical signal;
(f) recording the variations of said electrical signals with time.
(a) providing a plurality of sample DNAs, each disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm, (c) detecting the light level emitted from a plurality of reaction sites on respective portions of an optically sensitive device;
(d) converting the light impinging upon each of said portions of said optically sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions;
(e) determining a light intensity for each of said discrete regions from the corresponding electrical signal;
(f) recording the variations of said electrical signals with time.
180. Method for sequencing a nucleic acid, the method comprising:
(a) providing one or more nucleic acid anchor primers;
(b) providing a plurality of single-stranded circular nucleic acid templates disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm;
(c) detecting the light level emitted from a plurality of reaction sites on respective portions of an optically sensitive device;
(d) converting the light impinging upon each of said portions of said optically sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions;
(e) determining a light intensity for each of said discrete regions from the corresponding electrical signal;
(f) recording the variations of said electrical signals with time.
(a) providing one or more nucleic acid anchor primers;
(b) providing a plurality of single-stranded circular nucleic acid templates disposed within a plurality of cavities on a planar surface, each cavity forming an analyte reaction chamber, wherein the reaction chambers have a center to center spacing of between 5 to 200 µm;
(c) detecting the light level emitted from a plurality of reaction sites on respective portions of an optically sensitive device;
(d) converting the light impinging upon each of said portions of said optically sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions;
(e) determining a light intensity for each of said discrete regions from the corresponding electrical signal;
(f) recording the variations of said electrical signals with time.
181. A method for sequencing a nucleic acid, the method comprising:
(a) providing at least one nucleic acid anchor primer;
(b) providing a plurality of single-stranded circular nucleic acid templates in an array having at least 400,000 discrete reaction sites;
(c) detecting the light level emitted from a plurality of reaction sites on respective portions of an optically sensitive device;
(d) converting the light impinging upon each of said portions of said optically sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions;
(e) determining a light intensity for each of said discrete regions from the corresponding electrical signal;
(f) recording the variations of said electrical signals with time.
(a) providing at least one nucleic acid anchor primer;
(b) providing a plurality of single-stranded circular nucleic acid templates in an array having at least 400,000 discrete reaction sites;
(c) detecting the light level emitted from a plurality of reaction sites on respective portions of an optically sensitive device;
(d) converting the light impinging upon each of said portions of said optically sensitive device into an electrical signal which is distinguishable from the signals from all of said other regions;
(e) determining a light intensity for each of said discrete regions from the corresponding electrical signal;
(f) recording the variations of said electrical signals with time.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/814,338 | 2001-03-21 | ||
US09/814,338 US7244559B2 (en) | 1999-09-16 | 2001-03-21 | Method of sequencing a nucleic acid |
PCT/US2002/008700 WO2002077287A1 (en) | 2001-03-21 | 2002-03-21 | Apparatus and method for sequencing a nucleic acid |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2441603A1 true CA2441603A1 (en) | 2002-10-03 |
CA2441603C CA2441603C (en) | 2012-01-10 |
Family
ID=25214762
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2441603A Expired - Fee Related CA2441603C (en) | 2001-03-21 | 2002-03-21 | Apparatus and method for sequencing a nucleic acid |
Country Status (9)
Country | Link |
---|---|
US (5) | US7244559B2 (en) |
EP (1) | EP1381693B1 (en) |
JP (1) | JP4354184B2 (en) |
AT (1) | ATE468915T1 (en) |
AU (1) | AU2002247390B9 (en) |
CA (1) | CA2441603C (en) |
DE (1) | DE60236502D1 (en) |
ES (1) | ES2348435T3 (en) |
WO (1) | WO2002077287A1 (en) |
Families Citing this family (524)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994003624A1 (en) * | 1992-08-04 | 1994-02-17 | Auerbach Jeffrey I | Methods for the isothermal amplification of nucleic acid molecules |
US6261808B1 (en) * | 1992-08-04 | 2001-07-17 | Replicon, Inc. | Amplification of nucleic acid molecules via circular replicons |
US7875440B2 (en) | 1998-05-01 | 2011-01-25 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US6780591B2 (en) | 1998-05-01 | 2004-08-24 | Arizona Board Of Regents | Method of determining the nucleotide sequence of oligonucleotides and DNA molecules |
US7244559B2 (en) * | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US7211414B2 (en) | 2000-12-01 | 2007-05-01 | Visigen Biotechnologies, Inc. | Enzymatic nucleic acid synthesis: compositions and methods for altering monomer incorporation fidelity |
JP2002306180A (en) * | 2001-04-16 | 2002-10-22 | Hitachi Ltd | Method for analyzing nucleic acid base sequence, nucleic acid base sequence-analyzing reagent kit and nucleic acid base sequence-analyzing device |
WO2003004690A2 (en) * | 2001-07-06 | 2003-01-16 | 454$m(3) CORPORATION | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
US7595883B1 (en) * | 2002-09-16 | 2009-09-29 | The Board Of Trustees Of The Leland Stanford Junior University | Biological analysis arrangement and approach therefor |
EP2159285B1 (en) * | 2003-01-29 | 2012-09-26 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
US7575865B2 (en) * | 2003-01-29 | 2009-08-18 | 454 Life Sciences Corporation | Methods of amplifying and sequencing nucleic acids |
EP1590669B1 (en) * | 2003-02-05 | 2009-11-25 | The General Hospital Corporation | A microchip-based system for hiv diagnostics |
US20040191801A1 (en) * | 2003-03-25 | 2004-09-30 | Heeger Alan J. | Reagentless, reusable bioelectronic detectors and their use as authentication devices |
US8003374B2 (en) | 2003-03-25 | 2011-08-23 | The Regents Of The University Of California | Reagentless, reusable, bioelectronic detectors |
EP2532745B1 (en) | 2003-07-05 | 2015-09-09 | The Johns Hopkins University | Method and Compositions for Detection and Enumeration of Genetic Variations |
US7169560B2 (en) | 2003-11-12 | 2007-01-30 | Helicos Biosciences Corporation | Short cycle methods for sequencing polynucleotides |
US20060019264A1 (en) * | 2003-12-01 | 2006-01-26 | Said Attiya | Method for isolation of independent, parallel chemical micro-reactions using a porous filter |
CN1942590B (en) * | 2004-02-18 | 2012-09-05 | 周小川 | Fluidic devices and methods for multiplex chemical and biochemical reactions |
DE602005020421D1 (en) | 2004-02-19 | 2010-05-20 | Helicos Biosciences Corp | METHOD FOR THE ANALYSIS OF POLYNUCLEOTIDE SEQUENCES |
GB2413796B (en) * | 2004-03-25 | 2006-03-29 | Global Genomics Ab | Methods and means for nucleic acid sequencing |
US7622281B2 (en) | 2004-05-20 | 2009-11-24 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and compositions for clonal amplification of nucleic acid |
US7692219B1 (en) | 2004-06-25 | 2010-04-06 | University Of Hawaii | Ultrasensitive biosensors |
US20060024711A1 (en) * | 2004-07-02 | 2006-02-02 | Helicos Biosciences Corporation | Methods for nucleic acid amplification and sequence determination |
US7745207B2 (en) | 2006-02-03 | 2010-06-29 | IntegenX, Inc. | Microfluidic devices |
US7170050B2 (en) | 2004-09-17 | 2007-01-30 | Pacific Biosciences Of California, Inc. | Apparatus and methods for optical analysis of molecules |
CA2579150C (en) * | 2004-09-17 | 2014-11-25 | Pacific Biosciences Of California, Inc. | Apparatus and method for analysis of molecules |
US7785785B2 (en) | 2004-11-12 | 2010-08-31 | The Board Of Trustees Of The Leland Stanford Junior University | Charge perturbation detection system for DNA and other molecules |
US7629173B2 (en) * | 2004-12-29 | 2009-12-08 | Corning Incorporated | Optical reader system and method for monitoring and correcting lateral and angular misalignments of label independent biosensors |
EP2233582A1 (en) | 2005-02-01 | 2010-09-29 | AB Advanced Genetic Analysis Corporation | Nucleic acid sequencing by performing successive cycles of duplex extension |
WO2006084132A2 (en) | 2005-02-01 | 2006-08-10 | Agencourt Bioscience Corp. | Reagents, methods, and libraries for bead-based squencing |
US7964413B2 (en) * | 2005-03-10 | 2011-06-21 | Gen-Probe Incorporated | Method for continuous mode processing of multiple reaction receptacles in a real-time amplification assay |
US7785862B2 (en) | 2005-04-07 | 2010-08-31 | 454 Life Sciences Corporation | Thin film coated microwell arrays |
US7682816B2 (en) * | 2005-04-07 | 2010-03-23 | 454 Life Sciences Corporation | Thin film coated microwell arrays and methods of using same |
US20060228721A1 (en) * | 2005-04-12 | 2006-10-12 | Leamon John H | Methods for determining sequence variants using ultra-deep sequencing |
US9410889B2 (en) * | 2005-06-10 | 2016-08-09 | Applied Biosystem, Llc | Method and system for multiplex genetic analysis |
EP2463386B1 (en) | 2005-06-15 | 2017-04-12 | Complete Genomics Inc. | Nucleic acid analysis by random mixtures of non-overlapping fragments |
US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
US7981365B2 (en) * | 2005-09-15 | 2011-07-19 | The United States Of America As Represented By The Secretary Of The Navy | Electrospray coating of aerosols for labeling and identification |
US7960104B2 (en) | 2005-10-07 | 2011-06-14 | Callida Genomics, Inc. | Self-assembled single molecule arrays and uses thereof |
CA2624896C (en) * | 2005-10-07 | 2017-11-07 | Callida Genomics, Inc. | Self-assembled single molecule arrays and uses thereof |
WO2007133831A2 (en) * | 2006-02-24 | 2007-11-22 | Callida Genomics, Inc. | High throughput genome sequencing on dna arrays |
WO2007120208A2 (en) * | 2005-11-14 | 2007-10-25 | President And Fellows Of Harvard College | Nanogrid rolling circle dna sequencing |
DE102005056016A1 (en) * | 2005-11-17 | 2007-05-31 | Leibniz-Institut Für Polymerforschung Dresden E.V. | Structurable polymer layer composite, process for its preparation and application |
WO2007120299A2 (en) * | 2005-11-29 | 2007-10-25 | The Regents Of The University Of California | Signal-on architecture for electronic, oligonucleotide-based detectors |
US20070168197A1 (en) * | 2006-01-18 | 2007-07-19 | Nokia Corporation | Audio coding |
EP2002367B1 (en) * | 2006-02-16 | 2017-03-29 | 454 Life Sciences Corporation | System and method for correcting primer extension errors in nucleic acid sequence data |
US8364417B2 (en) | 2007-02-15 | 2013-01-29 | 454 Life Sciences Corporation | System and method to correct out of phase errors in DNA sequencing data by use of a recursive algorithm |
US8460879B2 (en) * | 2006-02-21 | 2013-06-11 | The Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
US11237171B2 (en) | 2006-02-21 | 2022-02-01 | Trustees Of Tufts College | Methods and arrays for target analyte detection and determination of target analyte concentration in solution |
SG10201405158QA (en) * | 2006-02-24 | 2014-10-30 | Callida Genomics Inc | High throughput genome sequencing on dna arrays |
US8071296B2 (en) | 2006-03-13 | 2011-12-06 | Agency For Science, Technology And Research | Nucleic acid interaction analysis |
KR101151486B1 (en) * | 2006-03-20 | 2012-05-30 | 미쓰이 가가쿠 가부시키가이샤 | Optical film and method for producing same |
US20090062129A1 (en) * | 2006-04-19 | 2009-03-05 | Agencourt Personal Genomics, Inc. | Reagents, methods, and libraries for gel-free bead-based sequencing |
US10522240B2 (en) | 2006-05-03 | 2019-12-31 | Population Bio, Inc. | Evaluating genetic disorders |
US7702468B2 (en) * | 2006-05-03 | 2010-04-20 | Population Diagnostics, Inc. | Evaluating genetic disorders |
US8614278B2 (en) | 2006-06-06 | 2013-12-24 | Dow Corning Corporation | Silicone acrylate hybrid composition and method of making same |
US8569416B2 (en) | 2006-06-06 | 2013-10-29 | Dow Corning Corporation | Single phase silicone acrylate formulation |
WO2007145996A2 (en) | 2006-06-06 | 2007-12-21 | Dow Corning Corporation | A silicone acrylate hybrid composition |
EP2548972A1 (en) | 2006-06-14 | 2013-01-23 | Verinata Health, Inc | Methods for the diagnosis of fetal abnormalities |
US20080070792A1 (en) * | 2006-06-14 | 2008-03-20 | Roland Stoughton | Use of highly parallel snp genotyping for fetal diagnosis |
US20080050739A1 (en) * | 2006-06-14 | 2008-02-28 | Roland Stoughton | Diagnosis of fetal abnormalities using polymorphisms including short tandem repeats |
US8372584B2 (en) | 2006-06-14 | 2013-02-12 | The General Hospital Corporation | Rare cell analysis using sample splitting and DNA tags |
US8137912B2 (en) | 2006-06-14 | 2012-03-20 | The General Hospital Corporation | Methods for the diagnosis of fetal abnormalities |
WO2008070352A2 (en) | 2006-10-27 | 2008-06-12 | Complete Genomics, Inc. | Efficient arrays of amplified polynucleotides |
JP2008109864A (en) * | 2006-10-30 | 2008-05-15 | Hitachi Ltd | Genetic sequence analysis system |
WO2008058018A2 (en) | 2006-11-02 | 2008-05-15 | Mayo Foundation For Medical Education And Research | Predicting cancer outcome |
US20090111706A1 (en) | 2006-11-09 | 2009-04-30 | Complete Genomics, Inc. | Selection of dna adaptor orientation by amplification |
US20080221832A1 (en) * | 2006-11-09 | 2008-09-11 | Complete Genomics, Inc. | Methods for computing positional base probabilities using experminentals base value distributions |
EP2518162B1 (en) | 2006-11-15 | 2018-03-07 | Biospherex LLC | Multitag sequencing and ecogenomics analysis |
US20080242560A1 (en) * | 2006-11-21 | 2008-10-02 | Gunderson Kevin L | Methods for generating amplified nucleic acid arrays |
US7813013B2 (en) * | 2006-11-21 | 2010-10-12 | Illumina, Inc. | Hexagonal site line scanning method and system |
US20100190654A1 (en) * | 2006-12-05 | 2010-07-29 | Liquidia Technologies , Inc. | Nanoarrays and methods and materials for fabricating same |
WO2008073378A2 (en) * | 2006-12-11 | 2008-06-19 | Thomas Jefferson University Medical College | High throughput dna sequencing method and apparatus |
US8349167B2 (en) | 2006-12-14 | 2013-01-08 | Life Technologies Corporation | Methods and apparatus for detecting molecular interactions using FET arrays |
US11339430B2 (en) | 2007-07-10 | 2022-05-24 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
US8262900B2 (en) * | 2006-12-14 | 2012-09-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes using large scale FET arrays |
EP2653861B1 (en) | 2006-12-14 | 2014-08-13 | Life Technologies Corporation | Method for sequencing a nucleic acid using large-scale FET arrays |
US7932034B2 (en) | 2006-12-20 | 2011-04-26 | The Board Of Trustees Of The Leland Stanford Junior University | Heat and pH measurement for sequencing of DNA |
EP2121984A2 (en) * | 2007-03-16 | 2009-11-25 | 454 Life Sciences Corporation | System and method for detection of hiv drug resistant variants |
US20080243865A1 (en) * | 2007-03-28 | 2008-10-02 | Oracle International Corporation | Maintaining global state of distributed transaction managed by an external transaction manager for clustered database systems |
EP2164985A4 (en) * | 2007-06-01 | 2014-05-14 | 454 Life Sciences Corp | System and meth0d for identification of individual samples from a multiplex mixture |
US20110105366A1 (en) * | 2007-06-18 | 2011-05-05 | Illumina, Inc. | Microfabrication methods for the optimal patterning of substrates |
CA2689389A1 (en) * | 2007-06-28 | 2009-01-08 | 454 Life Sciences Corporation | System and method for adaptive reagent control in nucleic acid sequencing |
JP5020734B2 (en) * | 2007-07-31 | 2012-09-05 | 株式会社日立ハイテクノロジーズ | Nucleic acid analysis method and apparatus |
CA2734029C (en) | 2007-08-30 | 2016-03-29 | The Trustees Of Tufts College | Methods for determining the concentration of an analyte in solution |
MX2010003724A (en) * | 2007-10-04 | 2010-09-14 | Halcyon Molecular | Sequencing nucleic acid polymers with electron microscopy. |
US8951731B2 (en) * | 2007-10-15 | 2015-02-10 | Complete Genomics, Inc. | Sequence analysis using decorated nucleic acids |
US7811810B2 (en) | 2007-10-25 | 2010-10-12 | Industrial Technology Research Institute | Bioassay system including optical detection apparatuses, and method for detecting biomolecules |
US7767441B2 (en) * | 2007-10-25 | 2010-08-03 | Industrial Technology Research Institute | Bioassay system including optical detection apparatuses, and method for detecting biomolecules |
US8518640B2 (en) * | 2007-10-29 | 2013-08-27 | Complete Genomics, Inc. | Nucleic acid sequencing and process |
US8415099B2 (en) | 2007-11-05 | 2013-04-09 | Complete Genomics, Inc. | Efficient base determination in sequencing reactions |
US20090263872A1 (en) * | 2008-01-23 | 2009-10-22 | Complete Genomics Inc. | Methods and compositions for preventing bias in amplification and sequencing reactions |
US7897344B2 (en) * | 2007-11-06 | 2011-03-01 | Complete Genomics, Inc. | Methods and oligonucleotide designs for insertion of multiple adaptors into library constructs |
US8617811B2 (en) * | 2008-01-28 | 2013-12-31 | Complete Genomics, Inc. | Methods and compositions for efficient base calling in sequencing reactions |
EP2215209B1 (en) | 2007-10-30 | 2018-05-23 | Complete Genomics, Inc. | Apparatus for high throughput sequencing of nucleic acids |
WO2009061840A1 (en) * | 2007-11-05 | 2009-05-14 | Complete Genomics, Inc. | Methods and oligonucleotide designs for insertion of multiple adaptors employing selective methylation |
WO2009073629A2 (en) * | 2007-11-29 | 2009-06-11 | Complete Genomics, Inc. | Efficient shotgun sequencing methods |
US9551026B2 (en) | 2007-12-03 | 2017-01-24 | Complete Genomincs, Inc. | Method for nucleic acid detection using voltage enhancement |
US8592150B2 (en) | 2007-12-05 | 2013-11-26 | Complete Genomics, Inc. | Methods and compositions for long fragment read sequencing |
EP4053546A1 (en) * | 2007-12-06 | 2022-09-07 | Genalyte, Inc. | Device and method for performing label-free monitoring of processes. |
US8815576B2 (en) * | 2007-12-27 | 2014-08-26 | Lawrence Livermore National Security, Llc. | Chip-based sequencing nucleic acids |
US20090181390A1 (en) * | 2008-01-11 | 2009-07-16 | Signosis, Inc. A California Corporation | High throughput detection of micrornas and use for disease diagnosis |
EP2620511B1 (en) | 2008-01-17 | 2018-02-28 | Sequenom, Inc. | Single molecule nucleic acid sequence analysis processes |
US20090203086A1 (en) * | 2008-02-06 | 2009-08-13 | 454 Life Sciences Corporation | System and method for improved signal detection in nucleic acid sequencing |
CN104862383B (en) | 2008-03-28 | 2019-05-28 | 加利福尼亚太平洋生物科学股份有限公司 | Composition and method for nucleic acid sequencing |
GB0809069D0 (en) | 2008-05-19 | 2008-06-25 | Univ Leuven Kath | Gene signatures |
US20090270273A1 (en) * | 2008-04-21 | 2009-10-29 | Complete Genomics, Inc. | Array structures for nucleic acid detection |
DE102008001322A1 (en) * | 2008-04-22 | 2009-10-29 | Linos Photonics Gmbh & Co. Kg | Sample array analysis system for use in e.g. pharma research, has detector detecting luminescence radiation emitted by samples, and light conductor array arranged in front of sample plate for conducting light on samples |
US8039817B2 (en) | 2008-05-05 | 2011-10-18 | Illumina, Inc. | Compensator for multiple surface imaging |
US20110105356A1 (en) * | 2008-05-07 | 2011-05-05 | Derosier Chad F | Compositions and methods for providing substances to and from an array |
EP2291553A4 (en) | 2008-05-28 | 2011-12-14 | Genomedx Biosciences Inc | Systems and methods for expression-based discrimination of distinct clinical disease states in prostate cancer |
US10407731B2 (en) | 2008-05-30 | 2019-09-10 | Mayo Foundation For Medical Education And Research | Biomarker panels for predicting prostate cancer outcomes |
JP5667049B2 (en) | 2008-06-25 | 2015-02-12 | ライフ テクノロジーズ コーポレーション | Method and apparatus for measuring analytes using large-scale FET arrays |
CN101368206B (en) * | 2008-07-16 | 2012-08-22 | 深圳华因康基因科技有限公司 | Sequencing reaction small chamber, gene sequencing reaction bench and gene sequencing device |
WO2010009426A2 (en) * | 2008-07-17 | 2010-01-21 | Life Technologies Corporation | Devices and methods for reagent delivery |
US20100035252A1 (en) * | 2008-08-08 | 2010-02-11 | Ion Torrent Systems Incorporated | Methods for sequencing individual nucleic acids under tension |
US20100227327A1 (en) * | 2008-08-08 | 2010-09-09 | Xiaoliang Sunney Xie | Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides |
US20100036110A1 (en) * | 2008-08-08 | 2010-02-11 | Xiaoliang Sunney Xie | Methods and compositions for continuous single-molecule nucleic acid sequencing by synthesis with fluorogenic nucleotides |
JP5184642B2 (en) * | 2008-09-08 | 2013-04-17 | 株式会社日立製作所 | DNA detection apparatus, DNA detection device, and DNA detection method |
US8383345B2 (en) | 2008-09-12 | 2013-02-26 | University Of Washington | Sequence tag directed subassembly of short sequencing reads into long sequencing reads |
EP3378951B1 (en) | 2008-09-20 | 2020-05-13 | The Board of Trustees of the Leland Stanford Junior University | Noninvasive diagnosis of aneuploidy by sequencing |
US20100075439A1 (en) * | 2008-09-23 | 2010-03-25 | Quanterix Corporation | Ultra-sensitive detection of molecules by capture-and-release using reducing agents followed by quantification |
US20100075862A1 (en) * | 2008-09-23 | 2010-03-25 | Quanterix Corporation | High sensitivity determination of the concentration of analyte molecules or particles in a fluid sample |
US8222047B2 (en) | 2008-09-23 | 2012-07-17 | Quanterix Corporation | Ultra-sensitive detection of molecules on single molecule arrays |
US20100301398A1 (en) | 2009-05-29 | 2010-12-02 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US20100137143A1 (en) | 2008-10-22 | 2010-06-03 | Ion Torrent Systems Incorporated | Methods and apparatus for measuring analytes |
US9846126B2 (en) | 2008-10-27 | 2017-12-19 | Genalyte, Inc. | Biosensors based on optical probing and sensing |
US8486630B2 (en) | 2008-11-07 | 2013-07-16 | Industrial Technology Research Institute | Methods for accurate sequence data and modified base position determination |
US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
US10236078B2 (en) | 2008-11-17 | 2019-03-19 | Veracyte, Inc. | Methods for processing or analyzing a sample of thyroid tissue |
AU2009314502B2 (en) | 2008-11-17 | 2015-01-22 | Veracyte, Inc. | Methods and compositions of molecular profiling for disease diagnostics |
EP2373817A4 (en) * | 2008-12-10 | 2013-01-02 | Illumina Inc | Methods and compositions for hybridizing nucleic acids |
CN102333891A (en) * | 2009-01-20 | 2012-01-25 | 利兰·斯坦福青年大学托管委员会 | Single cell gene expression for diagnosis, prognosis and identification of drug targets |
US9074258B2 (en) | 2009-03-04 | 2015-07-07 | Genomedx Biosciences Inc. | Compositions and methods for classifying thyroid nodule disease |
US20100285970A1 (en) * | 2009-03-31 | 2010-11-11 | Rose Floyd D | Methods of sequencing nucleic acids |
US9085798B2 (en) | 2009-04-30 | 2015-07-21 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
AU2010242073C1 (en) | 2009-04-30 | 2015-12-24 | Good Start Genetics, Inc. | Methods and compositions for evaluating genetic markers |
CN102459636B (en) | 2009-05-07 | 2016-08-17 | 威拉赛特公司 | For diagnosing the method and composition of disorder of thyroid gland |
US20120261274A1 (en) | 2009-05-29 | 2012-10-18 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US8776573B2 (en) | 2009-05-29 | 2014-07-15 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US8574835B2 (en) | 2009-05-29 | 2013-11-05 | Life Technologies Corporation | Scaffolded nucleic acid polymer particles and methods of making and using |
US8673627B2 (en) | 2009-05-29 | 2014-03-18 | Life Technologies Corporation | Apparatus and methods for performing electrochemical reactions |
US9524369B2 (en) | 2009-06-15 | 2016-12-20 | Complete Genomics, Inc. | Processing and analysis of complex nucleic acid sequence data |
EP2280080A1 (en) * | 2009-07-31 | 2011-02-02 | Qiagen GmbH | Method of normalized quantification of nucleic acids using anchor oligonucleotides and adapter oligonucleotides |
US10174368B2 (en) * | 2009-09-10 | 2019-01-08 | Centrillion Technology Holdings Corporation | Methods and systems for sequencing long nucleic acids |
CN102858995B (en) | 2009-09-10 | 2016-10-26 | 森特瑞隆技术控股公司 | Targeting sequence measurement |
SG10201405883XA (en) | 2009-09-23 | 2014-11-27 | Celmatix Inc | Methods and devices for assessing infertility and/or egg quality |
HUE052213T2 (en) | 2009-11-06 | 2021-04-28 | Univ Leland Stanford Junior | Non-invasive diagnosis of graft rejection in organ transplant patients |
JP5441035B2 (en) * | 2009-11-06 | 2014-03-12 | 国立大学法人北陸先端科学技術大学院大学 | Sample analyzer |
US8772016B2 (en) | 2009-11-13 | 2014-07-08 | Pacific Biosciences Of California, Inc. | Sealed chip package |
US10446272B2 (en) | 2009-12-09 | 2019-10-15 | Veracyte, Inc. | Methods and compositions for classification of samples |
US20110312503A1 (en) | 2010-01-23 | 2011-12-22 | Artemis Health, Inc. | Methods of fetal abnormality detection |
WO2011094865A1 (en) * | 2010-02-02 | 2011-08-11 | Arash Zarrine-Afsar | Fluid sampling device and method of use thereof |
US8575124B2 (en) | 2010-02-18 | 2013-11-05 | Anthony P. Shuber | Compositions and methods for treating cancer |
US8415171B2 (en) | 2010-03-01 | 2013-04-09 | Quanterix Corporation | Methods and systems for extending dynamic range in assays for the detection of molecules or particles |
US9678068B2 (en) * | 2010-03-01 | 2017-06-13 | Quanterix Corporation | Ultra-sensitive detection of molecules using dual detection methods |
US8236574B2 (en) | 2010-03-01 | 2012-08-07 | Quanterix Corporation | Ultra-sensitive detection of molecules or particles using beads or other capture objects |
ES2544635T3 (en) | 2010-03-01 | 2015-09-02 | Quanterix Corporation | Methods to extend the dynamic range in assays for the detection of molecules or particles |
US10787701B2 (en) | 2010-04-05 | 2020-09-29 | Prognosys Biosciences, Inc. | Spatially encoded biological assays |
US20190300945A1 (en) | 2010-04-05 | 2019-10-03 | Prognosys Biosciences, Inc. | Spatially Encoded Biological Assays |
ES2555106T3 (en) | 2010-04-05 | 2015-12-29 | Prognosys Biosciences, Inc. | Spatially coded biological assays |
US9234240B2 (en) | 2010-05-07 | 2016-01-12 | The Board Of Trustees Of The Leland Stanford Junior University | Measurement and comparison of immune diversity by high-throughput sequencing |
WO2011143361A2 (en) | 2010-05-11 | 2011-11-17 | Veracyte, Inc. | Methods and compositions for diagnosing conditions |
US20110287432A1 (en) | 2010-05-21 | 2011-11-24 | 454 Life Science Corporation | System and method for tailoring nucleotide concentration to enzymatic efficiencies in dna sequencing technologies |
EP2580353B1 (en) | 2010-06-11 | 2015-07-29 | Life Technologies Corporation | Alternative nucleotide flows in sequencing-by-synthesis methods |
WO2012003363A1 (en) | 2010-06-30 | 2012-01-05 | Life Technologies Corporation | Ion-sensing charge-accumulation circuits and methods |
EP2598804B1 (en) | 2010-06-30 | 2021-10-20 | Life Technologies Corporation | Method to generate an output signal in an isfet-array |
TWI569025B (en) | 2010-06-30 | 2017-02-01 | 生命技術公司 | Methods and apparatus for testing isfet arrays |
US11307166B2 (en) | 2010-07-01 | 2022-04-19 | Life Technologies Corporation | Column ADC |
US8653567B2 (en) | 2010-07-03 | 2014-02-18 | Life Technologies Corporation | Chemically sensitive sensor with lightly doped drains |
CN103392182B (en) | 2010-08-02 | 2017-07-04 | 众有生物有限公司 | System and method for finding pathogenic mutation in genetic disease |
WO2012024658A2 (en) | 2010-08-20 | 2012-02-23 | IntegenX, Inc. | Integrated analysis system |
US9618475B2 (en) | 2010-09-15 | 2017-04-11 | Life Technologies Corporation | Methods and apparatus for measuring analytes |
US8483969B2 (en) | 2010-09-17 | 2013-07-09 | Illuminia, Inc. | Variation analysis for multiple templates on a solid support |
IN2013MN00522A (en) | 2010-09-24 | 2015-05-29 | Univ Leland Stanford Junior | |
EP2619564B1 (en) | 2010-09-24 | 2016-03-16 | Life Technologies Corporation | Matched pair transistor circuits |
US20120077716A1 (en) | 2010-09-29 | 2012-03-29 | 454 Life Sciences Corporation | System and method for producing functionally distinct nucleic acid library ends through use of deoxyinosine |
WO2012050920A1 (en) | 2010-09-29 | 2012-04-19 | Illumina, Inc. | Compositions and methods for sequencing nucleic acids |
US10273540B2 (en) | 2010-10-27 | 2019-04-30 | Life Technologies Corporation | Methods and apparatuses for estimating parameters in a predictive model for use in sequencing-by-synthesis |
WO2012058459A2 (en) | 2010-10-27 | 2012-05-03 | Life Technologies Corporation | Predictive model for use in sequencing-by-synthesis |
CA3060724A1 (en) | 2010-11-05 | 2012-05-10 | Genalyte, Inc. | Optical analyte detection systems and methods of use |
US9074251B2 (en) | 2011-02-10 | 2015-07-07 | Illumina, Inc. | Linking sequence reads using paired code tags |
CA2819378A1 (en) | 2010-12-02 | 2012-06-07 | Katholieke Universiteit Leuven, K.U.Leuven R&D | Irak-related interventions and diagnosis |
EP2652659B1 (en) | 2010-12-14 | 2020-04-15 | Life Technologies Corporation | Systems and methods for run-time sequencing run quality monitoring |
US9163281B2 (en) | 2010-12-23 | 2015-10-20 | Good Start Genetics, Inc. | Methods for maintaining the integrity and identification of a nucleic acid template in a multiplex sequencing reaction |
WO2012118555A1 (en) | 2010-12-29 | 2012-09-07 | Life Technologies Corporation | Time-warped background signal for sequencing-by-synthesis operations |
WO2012092455A2 (en) | 2010-12-30 | 2012-07-05 | Life Technologies Corporation | Models for analyzing data from sequencing-by-synthesis operations |
US20130060482A1 (en) | 2010-12-30 | 2013-03-07 | Life Technologies Corporation | Methods, systems, and computer readable media for making base calls in nucleic acid sequencing |
US10241075B2 (en) | 2010-12-30 | 2019-03-26 | Life Technologies Corporation | Methods, systems, and computer readable media for nucleic acid sequencing |
CN102146442B (en) * | 2010-12-31 | 2014-10-22 | 深圳华因康基因科技有限公司 | Method and system for controlling sequencing process of gene sequencer |
CN102174384B (en) * | 2011-01-05 | 2014-04-02 | 深圳华因康基因科技有限公司 | Method and system for controlling sequencing and signal processing of gene sequencer |
US9217132B2 (en) | 2011-01-20 | 2015-12-22 | Ibis Biosciences, Inc. | Microfluidic transducer |
US9952237B2 (en) | 2011-01-28 | 2018-04-24 | Quanterix Corporation | Systems, devices, and methods for ultra-sensitive detection of molecules or particles |
EP2670863B1 (en) | 2011-01-31 | 2018-06-27 | H. Hoffnabb-La Roche Ag | Methods of identifying multiple epitopes in cells |
EP2670894B1 (en) | 2011-02-02 | 2017-11-29 | University Of Washington Through Its Center For Commercialization | Massively parallel continguity mapping |
ES2666301T3 (en) | 2011-03-09 | 2018-05-03 | Cell Signaling Technology, Inc. | Methods and reagents to create monoclonal antibodies |
US20120252682A1 (en) | 2011-04-01 | 2012-10-04 | Maples Corporate Services Limited | Methods and systems for sequencing nucleic acids |
CN105861645B (en) | 2011-04-08 | 2020-02-21 | 生命科技股份有限公司 | Phase-protected reagent flow ordering for use in sequencing-by-synthesis |
WO2012142301A2 (en) | 2011-04-12 | 2012-10-18 | Quanterix Corporation | Methods of determining a treatment protocol for and/or a prognosis of a patients recovery from a brain injury |
GB201106254D0 (en) | 2011-04-13 | 2011-05-25 | Frisen Jonas | Method and product |
EP3907297A1 (en) | 2011-04-15 | 2021-11-10 | The Johns Hopkins University | Safe sequencing system |
WO2012168803A2 (en) | 2011-06-07 | 2012-12-13 | Koninklijke Philips Electronics N.V. | Providing nucleotide sequence data |
US8778848B2 (en) | 2011-06-09 | 2014-07-15 | Illumina, Inc. | Patterned flow-cells useful for nucleic acid analysis |
US10704164B2 (en) | 2011-08-31 | 2020-07-07 | Life Technologies Corporation | Methods, systems, computer readable media, and kits for sample identification |
DE102011054101A1 (en) | 2011-09-30 | 2013-04-04 | Albert-Ludwigs-Universität Freiburg | Method for the spatial arrangement of sample fragments for amplification and immobilization for further derivatizations |
US10221454B2 (en) | 2011-10-10 | 2019-03-05 | The Hospital For Sick Children | Methods and compositions for screening and treating developmental disorders |
CA2852665A1 (en) | 2011-10-17 | 2013-04-25 | Good Start Genetics, Inc. | Analysis methods |
SG11201401628WA (en) | 2011-10-19 | 2014-05-29 | Nugen Technologies Inc | Compositions and methods for directional nucleic acid amplification and sequencing |
US10865440B2 (en) | 2011-10-21 | 2020-12-15 | IntegenX, Inc. | Sample preparation, processing and analysis systems |
US20150136604A1 (en) | 2011-10-21 | 2015-05-21 | Integenx Inc. | Sample preparation, processing and analysis systems |
DE102011085473A1 (en) | 2011-10-28 | 2013-05-02 | Albert-Ludwigs-Universität Freiburg | Method for the identification of aptamers |
WO2013063382A2 (en) | 2011-10-28 | 2013-05-02 | Illumina, Inc. | Microarray fabrication system and method |
US10837879B2 (en) | 2011-11-02 | 2020-11-17 | Complete Genomics, Inc. | Treatment for stabilizing nucleic acid arrays |
EP2773779B1 (en) | 2011-11-04 | 2020-10-14 | Population Bio, Inc. | Methods and compositions for diagnosing, prognosing, and treating neurological conditions |
JP2015501974A (en) | 2011-11-07 | 2015-01-19 | インジェヌイティ システムズ インコーポレイテッド | Methods and systems for identification of causal genomic mutations. |
US9970984B2 (en) | 2011-12-01 | 2018-05-15 | Life Technologies Corporation | Method and apparatus for identifying defects in a chemical sensor array |
EP2791359B1 (en) | 2011-12-13 | 2020-01-15 | Decipher Biosciences, Inc. | Cancer diagnostics using non-coding transcripts |
JP6093498B2 (en) * | 2011-12-13 | 2017-03-08 | 株式会社日立ハイテクノロジーズ | Nucleic acid amplification method |
US9823246B2 (en) | 2011-12-28 | 2017-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Fluorescence enhancing plasmonic nanoscopic gold films and assays based thereon |
EP3434789A1 (en) | 2012-01-13 | 2019-01-30 | Data2Bio | Genotyping by next-generation sequencing |
US8821798B2 (en) | 2012-01-19 | 2014-09-02 | Life Technologies Corporation | Titanium nitride as sensing layer for microwell structure |
US8747748B2 (en) | 2012-01-19 | 2014-06-10 | Life Technologies Corporation | Chemical sensor with conductive cup-shaped sensor surface |
CA2862552A1 (en) | 2012-01-26 | 2013-08-01 | Nugen Technologies, Inc. | Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation |
DK2812452T3 (en) | 2012-02-09 | 2020-06-29 | Population Bio Inc | METHODS AND COMPOSITIONS FOR SCREENING AND TREATING DEVELOPMENT DISORDERS |
PL2814959T3 (en) | 2012-02-17 | 2018-07-31 | Fred Hutchinson Cancer Research Center | Compositions and methods for accurately identifying mutations |
US9803239B2 (en) | 2012-03-29 | 2017-10-31 | Complete Genomics, Inc. | Flow cells for high density array chips |
US8209130B1 (en) | 2012-04-04 | 2012-06-26 | Good Start Genetics, Inc. | Sequence assembly |
US8812422B2 (en) | 2012-04-09 | 2014-08-19 | Good Start Genetics, Inc. | Variant database |
US20130274148A1 (en) | 2012-04-11 | 2013-10-17 | Illumina, Inc. | Portable genetic detection and analysis system and method |
US8906320B1 (en) * | 2012-04-16 | 2014-12-09 | Illumina, Inc. | Biosensors for biological or chemical analysis and systems and methods for same |
US10227635B2 (en) | 2012-04-16 | 2019-03-12 | Molecular Loop Biosolutions, Llc | Capture reactions |
EP2659977B1 (en) | 2012-05-02 | 2019-04-24 | IMEC vzw | Microfluidics system for sequencing |
US9487828B2 (en) | 2012-05-10 | 2016-11-08 | The General Hospital Corporation | Methods for determining a nucleotide sequence contiguous to a known target nucleotide sequence |
US9646132B2 (en) | 2012-05-11 | 2017-05-09 | Life Technologies Corporation | Models for analyzing data from sequencing-by-synthesis operations |
US10192024B2 (en) | 2012-05-18 | 2019-01-29 | 454 Life Sciences Corporation | System and method for generation and use of optimal nucleotide flow orders |
CN102703301A (en) * | 2012-05-24 | 2012-10-03 | 中国科学院北京基因组研究所 | Darkroom used between installing seat of sequencing chip and CCD (Charge Coupled Device) camera |
CN102703302B (en) * | 2012-05-24 | 2013-11-27 | 中国科学院北京基因组研究所 | Installing seat for automatically clamping sequencing chip |
CN102703311B (en) * | 2012-05-24 | 2013-08-21 | 中国科学院北京基因组研究所 | Reaction bin for adaptive regulation of DNA (Deoxyribose Nucleic Acid) sequencer |
CN102703310B (en) * | 2012-05-24 | 2013-10-16 | 中国科学院北京基因组研究所 | CCD (charge coupled device) camera directly coupled with sequencing chip |
US8786331B2 (en) | 2012-05-29 | 2014-07-22 | Life Technologies Corporation | System for reducing noise in a chemical sensor array |
US9012022B2 (en) | 2012-06-08 | 2015-04-21 | Illumina, Inc. | Polymer coatings |
US8895249B2 (en) | 2012-06-15 | 2014-11-25 | Illumina, Inc. | Kinetic exclusion amplification of nucleic acid libraries |
DE102012210183B4 (en) * | 2012-06-18 | 2017-03-23 | Siemens Healthcare Gmbh | Arrangement and method for analyzing nucleic acid sequences |
JP6181751B2 (en) | 2012-06-18 | 2017-08-16 | ニューゲン テクノロジーズ, インコーポレイテッド | Compositions and methods for negative selection of unwanted nucleic acid sequences |
US20150011396A1 (en) | 2012-07-09 | 2015-01-08 | Benjamin G. Schroeder | Methods for creating directional bisulfite-converted nucleic acid libraries for next generation sequencing |
US10174310B2 (en) | 2012-08-08 | 2019-01-08 | Roche Sequencing Solutions, Inc. | Increasing dynamic range for identifying multiple epitopes in cells |
US11035005B2 (en) | 2012-08-16 | 2021-06-15 | Decipher Biosciences, Inc. | Cancer diagnostics using biomarkers |
DK2895621T3 (en) | 2012-09-14 | 2020-11-30 | Population Bio Inc | METHODS AND COMPOSITION FOR DIAGNOSIS, FORECAST AND TREATMENT OF NEUROLOGICAL CONDITIONS |
CN103092090B (en) * | 2012-09-14 | 2015-04-08 | 盛司潼 | Sequencing control system |
CA2922005A1 (en) | 2012-09-27 | 2014-04-03 | Population Diagnostics, Inc. | Methods and compositions for screening and treating developmental disorders |
US10329608B2 (en) | 2012-10-10 | 2019-06-25 | Life Technologies Corporation | Methods, systems, and computer readable media for repeat sequencing |
US9177098B2 (en) | 2012-10-17 | 2015-11-03 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
US10162800B2 (en) | 2012-10-17 | 2018-12-25 | Celmatix Inc. | Systems and methods for determining the probability of a pregnancy at a selected point in time |
US9181583B2 (en) | 2012-10-23 | 2015-11-10 | Illumina, Inc. | HLA typing using selective amplification and sequencing |
CN104956225B (en) | 2012-10-29 | 2018-10-02 | 约翰·霍普金斯大学 | Ovary and the test of the Pap test of carcinoma of endometrium |
US9836577B2 (en) | 2012-12-14 | 2017-12-05 | Celmatix, Inc. | Methods and devices for assessing risk of female infertility |
EP2746405B1 (en) | 2012-12-23 | 2015-11-04 | HS Diagnomics GmbH | Methods and primer sets for high throughput PCR sequencing |
US9080968B2 (en) | 2013-01-04 | 2015-07-14 | Life Technologies Corporation | Methods and systems for point of use removal of sacrificial material |
US9841398B2 (en) | 2013-01-08 | 2017-12-12 | Life Technologies Corporation | Methods for manufacturing well structures for low-noise chemical sensors |
US9683230B2 (en) | 2013-01-09 | 2017-06-20 | Illumina Cambridge Limited | Sample preparation on a solid support |
WO2014113502A1 (en) | 2013-01-15 | 2014-07-24 | Quanterix Corporation | Detection of dna or rna using single molecule arrays and other techniques |
US9128861B2 (en) | 2013-01-17 | 2015-09-08 | Personalis, Inc. | Methods and systems for genetic analysis |
WO2014116729A2 (en) | 2013-01-22 | 2014-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Haplotying of hla loci with ultra-deep shotgun sequencing |
US8962366B2 (en) | 2013-01-28 | 2015-02-24 | Life Technologies Corporation | Self-aligned well structures for low-noise chemical sensors |
US9411930B2 (en) | 2013-02-01 | 2016-08-09 | The Regents Of The University Of California | Methods for genome assembly and haplotype phasing |
GB2547875B (en) | 2013-02-01 | 2017-12-13 | Univ California | Methods for meta-genomics analysis of microbes |
US9512422B2 (en) | 2013-02-26 | 2016-12-06 | Illumina, Inc. | Gel patterned surfaces |
US8963216B2 (en) | 2013-03-13 | 2015-02-24 | Life Technologies Corporation | Chemical sensor with sidewall spacer sensor surface |
EP2970951B1 (en) | 2013-03-13 | 2019-02-20 | Illumina, Inc. | Methods for nucleic acid sequencing |
US8841217B1 (en) | 2013-03-13 | 2014-09-23 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
EP2971070B2 (en) | 2013-03-14 | 2021-03-03 | Illumina, Inc. | Modified polymerases for improved incorporation of nucleotide analogues |
WO2014152421A1 (en) | 2013-03-14 | 2014-09-25 | Good Start Genetics, Inc. | Methods for analyzing nucleic acids |
US20140296080A1 (en) | 2013-03-14 | 2014-10-02 | Life Technologies Corporation | Methods, Systems, and Computer Readable Media for Evaluating Variant Likelihood |
BR112015022490A2 (en) | 2013-03-15 | 2017-07-18 | Veracyte Inc | methods and compositions for sample classification |
DK2970959T3 (en) | 2013-03-15 | 2018-08-06 | Lineage Biosciences Inc | METHODS AND COMPOSITIONS FOR MARKING AND ANALYSIS OF SAMPLES |
EP2971130A4 (en) | 2013-03-15 | 2016-10-05 | Nugen Technologies Inc | Sequential sequencing |
EP2971152B1 (en) | 2013-03-15 | 2018-08-01 | The Board Of Trustees Of The Leland Stanford Junior University | Identification and use of circulating nucleic acid tumor markers |
WO2014149780A1 (en) | 2013-03-15 | 2014-09-25 | Life Technologies Corporation | Chemical sensor with consistent sensor surface areas |
US9983206B2 (en) | 2013-03-15 | 2018-05-29 | The Board Of Trustees Of The University Of Illinois | Methods and compositions for enhancing immunoassays |
US9116117B2 (en) | 2013-03-15 | 2015-08-25 | Life Technologies Corporation | Chemical sensor with sidewall sensor surface |
JP6581074B2 (en) | 2013-03-15 | 2019-09-25 | ライフ テクノロジーズ コーポレーション | Chemical sensor with consistent sensor surface area |
WO2014149779A1 (en) | 2013-03-15 | 2014-09-25 | Life Technologies Corporation | Chemical device with thin conductive element |
US9193998B2 (en) | 2013-03-15 | 2015-11-24 | Illumina, Inc. | Super resolution imaging |
US9835585B2 (en) | 2013-03-15 | 2017-12-05 | Life Technologies Corporation | Chemical sensor with protruded sensor surface |
US20140274747A1 (en) | 2013-03-15 | 2014-09-18 | Illumina, Inc. | Super resolution imaging |
WO2014139596A1 (en) | 2013-03-15 | 2014-09-18 | Illumina Cambridge Limited | Modified nucleosides or nucleotides |
US20140336063A1 (en) | 2013-05-09 | 2014-11-13 | Life Technologies Corporation | Windowed Sequencing |
US8847799B1 (en) | 2013-06-03 | 2014-09-30 | Good Start Genetics, Inc. | Methods and systems for storing sequence read data |
US10458942B2 (en) | 2013-06-10 | 2019-10-29 | Life Technologies Corporation | Chemical sensor array having multiple sensors per well |
WO2014210225A1 (en) | 2013-06-25 | 2014-12-31 | Prognosys Biosciences, Inc. | Methods and systems for determining spatial patterns of biological targets in a sample |
KR102070483B1 (en) | 2013-07-01 | 2020-01-29 | 일루미나, 인코포레이티드 | Catalyst-free surface functionalization and polymer grafting |
US9926597B2 (en) | 2013-07-26 | 2018-03-27 | Life Technologies Corporation | Control nucleic acid sequences for use in sequencing-by-synthesis and methods for designing the same |
KR102291045B1 (en) | 2013-08-05 | 2021-08-19 | 트위스트 바이오사이언스 코포레이션 | De novo synthesized gene libraries |
KR20160081896A (en) | 2013-08-30 | 2016-07-08 | 일루미나, 인코포레이티드 | Manipulation of droplets on hydrophilic or variegated-hydrophilic surfaces |
EP3965111A1 (en) | 2013-08-30 | 2022-03-09 | Personalis, Inc. | Methods and systems for genomic analysis |
SG10201913351XA (en) | 2013-09-05 | 2020-03-30 | Jackson Lab | Compositions for rna-chromatin interaction analysis and uses thereof |
US9352315B2 (en) | 2013-09-27 | 2016-05-31 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method to produce chemical pattern in micro-fluidic structure |
GB2535066A (en) | 2013-10-03 | 2016-08-10 | Personalis Inc | Methods for analyzing genotypes |
US10410739B2 (en) | 2013-10-04 | 2019-09-10 | Life Technologies Corporation | Methods and systems for modeling phasing effects in sequencing using termination chemistry |
WO2015057565A1 (en) | 2013-10-18 | 2015-04-23 | Good Start Genetics, Inc. | Methods for assessing a genomic region of a subject |
US10851414B2 (en) | 2013-10-18 | 2020-12-01 | Good Start Genetics, Inc. | Methods for determining carrier status |
WO2015070086A1 (en) | 2013-11-07 | 2015-05-14 | The Board Of Trustees Of The Leland Stanford Junior University | Cell-free nucleic acids for the analysis of the human microbiome and components thereof |
EP2891722B1 (en) | 2013-11-12 | 2018-10-10 | Population Bio, Inc. | Methods and compositions for diagnosing, prognosing, and treating endometriosis |
US9546399B2 (en) | 2013-11-13 | 2017-01-17 | Nugen Technologies, Inc. | Compositions and methods for identification of a duplicate sequencing read |
WO2015073999A1 (en) | 2013-11-18 | 2015-05-21 | Integenx Inc. | Cartridges and instruments for sample analysis |
CN111118121A (en) | 2013-12-05 | 2020-05-08 | 生捷科技控股公司 | Preparation of patterned arrays |
GB2537077B (en) | 2013-12-05 | 2018-05-09 | Centrillion Tech Holdings Corp | Methods for sequencing nucleic acids |
US10385335B2 (en) | 2013-12-05 | 2019-08-20 | Centrillion Technology Holdings Corporation | Modified surfaces |
EP3540074A1 (en) | 2013-12-11 | 2019-09-18 | The Regents of the University of California | Method of tagging internal regions of nucleic acid molecules |
JP6366719B2 (en) | 2013-12-20 | 2018-08-01 | イルミナ インコーポレイテッド | Preservation of genomic connectivity information in fragmented genomic DNA samples |
KR102475314B1 (en) | 2013-12-23 | 2022-12-06 | 일루미나, 인코포레이티드 | Structured substrates for improving detection of light emissions and methods relating to the same |
KR102001554B1 (en) | 2014-01-16 | 2019-07-18 | 일루미나, 인코포레이티드 | Amplicon preparation and sequencing on solid supports |
US9677132B2 (en) | 2014-01-16 | 2017-06-13 | Illumina, Inc. | Polynucleotide modification on solid support |
JP2015139373A (en) * | 2014-01-27 | 2015-08-03 | 株式会社日立ハイテクノロジーズ | Biomolecule analytical device, and biomolecule analyzer |
US20150211061A1 (en) * | 2014-01-27 | 2015-07-30 | The General Hospital Corporation | Methods for determining a nucleotide sequence |
EP3099820A4 (en) | 2014-01-27 | 2018-01-03 | The General Hospital Corporation | Methods of preparing nucleic acids for sequencing |
WO2015127517A1 (en) | 2014-02-27 | 2015-09-03 | Katholieke Universiteit Leuven | Oxidative stress and cardiovascular disease events |
US10704097B2 (en) | 2014-02-27 | 2020-07-07 | Katholieke Universiteit Leuven | Oxidative stress and cardiovascular disease events |
WO2015131107A1 (en) | 2014-02-28 | 2015-09-03 | Nugen Technologies, Inc. | Reduced representation bisulfite sequencing with diversity adaptors |
US11060139B2 (en) | 2014-03-28 | 2021-07-13 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
DK3129505T3 (en) | 2014-04-11 | 2021-10-04 | Redvault Biosciences Lp | Methods for clonal replication and amplification of nucleic acid molecules for genomic and therapeutic applications |
WO2015175530A1 (en) | 2014-05-12 | 2015-11-19 | Gore Athurva | Methods for detecting aneuploidy |
US10208332B2 (en) | 2014-05-21 | 2019-02-19 | Integenx Inc. | Fluidic cartridge with valve mechanism |
CA2952058A1 (en) | 2014-06-13 | 2015-12-17 | Illumina Cambridge Limited | Methods and compositions for preparing sequencing libraries |
US10017759B2 (en) | 2014-06-26 | 2018-07-10 | Illumina, Inc. | Library preparation of tagged nucleic acid |
ES2788949T3 (en) | 2014-06-27 | 2020-10-23 | Illumina Inc | Modified polymerases for improved incorporation of nucleotide analogs |
EP3161152B1 (en) | 2014-06-30 | 2018-12-26 | Illumina, Inc. | Methods and compositions using one-sided transposition |
US10208350B2 (en) | 2014-07-17 | 2019-02-19 | Celmatix Inc. | Methods and systems for assessing infertility and related pathologies |
AU2015294354B2 (en) | 2014-07-21 | 2021-10-28 | Illumina, Inc. | Polynucleotide enrichment using CRISPR-Cas systems |
EP3174980A4 (en) | 2014-08-01 | 2018-01-17 | Dovetail Genomics, LLC | Tagging nucleic acids for sequence assembly |
US10102337B2 (en) | 2014-08-06 | 2018-10-16 | Nugen Technologies, Inc. | Digital measurements from targeted sequencing |
GB201414098D0 (en) | 2014-08-08 | 2014-09-24 | Illumina Cambridge Ltd | Modified nucleotide linkers |
CN106796212A (en) | 2014-08-12 | 2017-05-31 | 新生代吉恩公司 | System and method for monitoring health based on the body fluid collected |
CN107076739B (en) | 2014-08-21 | 2018-12-25 | 伊卢米纳剑桥有限公司 | Reversible surface functionalization |
CA2996445A1 (en) | 2014-09-05 | 2016-03-10 | Eli Hatchwell | Methods and compositions for inhibiting and treating neurological conditions |
WO2016040446A1 (en) | 2014-09-10 | 2016-03-17 | Good Start Genetics, Inc. | Methods for selectively suppressing non-target sequences |
US10633694B2 (en) | 2014-09-12 | 2020-04-28 | Illumina, Inc. | Compositions, systems, and methods for detecting the presence of polymer subunits using chemiluminescence |
EP3224595A4 (en) | 2014-09-24 | 2018-06-13 | Good Start Genetics, Inc. | Process control for increased robustness of genetic assays |
WO2016054096A1 (en) | 2014-09-30 | 2016-04-07 | Illumina, Inc. | Modified polymerases for improved incorporation of nucleotide analogues |
WO2016060974A1 (en) | 2014-10-13 | 2016-04-21 | Life Technologies Corporation | Methods, systems, and computer-readable media for accelerated base calling |
CN106661575B (en) * | 2014-10-14 | 2020-03-24 | 深圳华大智造科技有限公司 | Linker element and method for constructing sequencing library by using same |
SG10201903408VA (en) | 2014-10-17 | 2019-05-30 | Illumina Cambridge Ltd | Contiguity preserving transposition |
US10690627B2 (en) | 2014-10-22 | 2020-06-23 | IntegenX, Inc. | Systems and methods for sample preparation, processing and analysis |
EP4026913A1 (en) | 2014-10-30 | 2022-07-13 | Personalis, Inc. | Methods for using mosaicism in nucleic acids sampled distal to their origin |
ES2772127T3 (en) | 2014-10-31 | 2020-07-07 | Illumina Cambridge Ltd | DNA copolymer polymers and coatings |
US20170335396A1 (en) | 2014-11-05 | 2017-11-23 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
WO2016073778A2 (en) | 2014-11-05 | 2016-05-12 | Nirmidas Biotech, Inc. | Metal composites for enhanced imaging |
CN114438174A (en) | 2014-11-11 | 2022-05-06 | 伊鲁米那股份有限公司 | Polynucleotide amplification using CRISPR-CAS system |
US11789906B2 (en) | 2014-11-19 | 2023-10-17 | Arc Bio, Llc | Systems and methods for genomic manipulations and analysis |
KR101750464B1 (en) * | 2014-11-28 | 2017-06-28 | 케이맥바이오센터주식회사 | The probe system for real time quantitative and qualitative analyzing of biomaterial, the reaction chamber with said probe system, and the analyzing method thereof |
KR102593647B1 (en) | 2014-12-18 | 2023-10-26 | 라이프 테크놀로지스 코포레이션 | High data rate integrated circuit with transmitter configuration |
US10077472B2 (en) | 2014-12-18 | 2018-09-18 | Life Technologies Corporation | High data rate integrated circuit with power management |
EP3234575B1 (en) | 2014-12-18 | 2023-01-25 | Life Technologies Corporation | Apparatus for measuring analytes using large scale fet arrays |
WO2016094970A1 (en) | 2014-12-19 | 2016-06-23 | Vrije Universiteit Brussel | In vitro maturation of a mammalian cumulus oocyte complex |
US10066259B2 (en) | 2015-01-06 | 2018-09-04 | Good Start Genetics, Inc. | Screening for structural variants |
GB2548763B (en) | 2015-02-02 | 2021-07-21 | Hitachi High Tech Corp | Multicolor fluorescence analysis device |
CA2975855A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Compositions and methods for synthetic gene assembly |
CA2975852A1 (en) | 2015-02-04 | 2016-08-11 | Twist Bioscience Corporation | Methods and devices for de novo oligonucleic acid assembly |
US9715573B2 (en) | 2015-02-17 | 2017-07-25 | Dovetail Genomics, Llc | Nucleic acid sequence assembly |
AU2016235288B2 (en) * | 2015-03-24 | 2019-02-28 | Illumina Cambridge Limited | Methods, carrier assemblies, and systems for imaging samples for biological or chemical analysis |
US11807896B2 (en) | 2015-03-26 | 2023-11-07 | Dovetail Genomics, Llc | Physical linkage preservation in DNA storage |
EP3901281B1 (en) | 2015-04-10 | 2022-11-23 | Spatial Transcriptomics AB | Spatially distinguished, multiplex nucleic acid analysis of biological specimens |
EP3283870B1 (en) | 2015-04-14 | 2020-05-06 | Illumina, Inc. | Structured substrates for improving detection of light emissions and methods relating to the same |
WO2016172377A1 (en) | 2015-04-21 | 2016-10-27 | Twist Bioscience Corporation | Devices and methods for oligonucleic acid library synthesis |
WO2016170182A1 (en) | 2015-04-24 | 2016-10-27 | Qiagen Gmbh | Method for immobilizing a nucleic acid molecule on a solid support |
WO2016170179A1 (en) | 2015-04-24 | 2016-10-27 | Qiagen Gmbh | Method for immobilizing a nucleic acid molecule on solid support |
EP4190912A1 (en) | 2015-05-11 | 2023-06-07 | Illumina, Inc. | Platform for discovery and analysis of therapeutic agents |
EP4220645A3 (en) | 2015-05-14 | 2023-11-08 | Life Technologies Corporation | Barcode sequences, and related systems and methods |
WO2016201111A1 (en) | 2015-06-09 | 2016-12-15 | Centrillion Technology Holdings Corporation | Methods for sequencing nucleic acids |
JP6698708B2 (en) | 2015-06-09 | 2020-05-27 | ライフ テクノロジーズ コーポレーション | Methods, systems, compositions, kits, devices, and computer-readable media for molecular tagging |
CN107924121B (en) | 2015-07-07 | 2021-06-08 | 亿明达股份有限公司 | Selective surface patterning via nanoimprinting |
US20180207920A1 (en) | 2015-07-17 | 2018-07-26 | Illumina, Inc. | Polymer sheets for sequencing applications |
WO2017015543A1 (en) | 2015-07-23 | 2017-01-26 | Asuragen, Inc. | Methods, compositions, kits, and uses for analysis of nucleic acids comprising repeating a/t-rich segments |
JP6946292B2 (en) | 2015-08-06 | 2021-10-06 | エイアールシー バイオ リミテッド ライアビリティ カンパニー | Systems and methods for genome analysis |
US11286531B2 (en) | 2015-08-11 | 2022-03-29 | The Johns Hopkins University | Assaying ovarian cyst fluid |
US10906044B2 (en) | 2015-09-02 | 2021-02-02 | Illumina Cambridge Limited | Methods of improving droplet operations in fluidic systems with a filler fluid including a surface regenerative silane |
KR20180050411A (en) | 2015-09-18 | 2018-05-14 | 트위스트 바이오사이언스 코포레이션 | Oligonucleotide mutant library and its synthesis |
CN113604546A (en) | 2015-09-22 | 2021-11-05 | 特韦斯特生物科学公司 | Flexible substrates for nucleic acid synthesis |
SG11201803289VA (en) | 2015-10-19 | 2018-05-30 | Dovetail Genomics Llc | Methods for genome assembly, haplotype phasing, and target independent nucleic acid detection |
WO2017095958A1 (en) | 2015-12-01 | 2017-06-08 | Twist Bioscience Corporation | Functionalized surfaces and preparation thereof |
CN113970589A (en) | 2016-01-22 | 2022-01-25 | 普度研究基金会 | Charged mass marking system |
FR3047251A1 (en) * | 2016-02-02 | 2017-08-04 | Dna Script | INSTALLATION FOR IMPLEMENTING A PROCESS FOR THE ENZYMATIC SYNTHESIS OF NUCLEIC ACIDS |
CA3014911A1 (en) | 2016-02-23 | 2017-08-31 | Dovetail Genomics, Llc | Generation of phased read-sets for genome assembly and haplotype phasing |
CA3185611A1 (en) | 2016-03-25 | 2017-09-28 | Karius, Inc. | Synthetic nucleic acid spike-ins |
US20170274374A1 (en) | 2016-03-28 | 2017-09-28 | Ilumina, Inc. | Multi-plane microarrays |
WO2017180909A1 (en) | 2016-04-13 | 2017-10-19 | Nextgen Jane, Inc. | Sample collection and preservation devices, systems and methods |
US11355328B2 (en) | 2016-04-13 | 2022-06-07 | Purdue Research Foundation | Systems and methods for isolating a target ion in an ion trap using a dual frequency waveform |
US10619205B2 (en) | 2016-05-06 | 2020-04-14 | Life Technologies Corporation | Combinatorial barcode sequences, and related systems and methods |
EP3656873A3 (en) | 2016-05-11 | 2020-07-29 | Illumina, Inc. | Polynucleotide enrichment and amplification using argonaute systems |
IL262946B2 (en) | 2016-05-13 | 2023-03-01 | Dovetail Genomics Llc | Recovering long-range linkage information from preserved samples |
US11299783B2 (en) | 2016-05-27 | 2022-04-12 | Personalis, Inc. | Methods and systems for genetic analysis |
CN107619859A (en) * | 2016-07-13 | 2018-01-23 | 广州康昕瑞基因健康科技有限公司 | Gene sequencing reaction device |
WO2018038772A1 (en) | 2016-08-22 | 2018-03-01 | Twist Bioscience Corporation | De novo synthesized nucleic acid libraries |
AU2017315252B2 (en) | 2016-08-22 | 2023-03-16 | Biolumic Limited | System, device and methods of seed treatment |
AU2017315425B2 (en) | 2016-08-24 | 2023-11-09 | The Regents Of The University Of Michigan | Use of genomic signatures to predict responsiveness of patients with prostate cancer to post-operative radiation therapy |
JP6997773B2 (en) | 2016-09-15 | 2022-01-18 | アーチャーディーエックス, エルエルシー | Method for preparing nucleic acid sample for analysis of cell-free DNA |
ES2903357T3 (en) | 2016-09-15 | 2022-04-01 | Archerdx Llc | Nucleic Acid Sample Preparation Methods |
KR102217487B1 (en) | 2016-09-21 | 2021-02-23 | 트위스트 바이오사이언스 코포레이션 | Nucleic acid-based data storage |
EP3519586B1 (en) | 2016-09-28 | 2024-03-13 | Life Technologies Corporation | Methods for sequencing nucleic acids using termination chemistry |
US10190155B2 (en) | 2016-10-14 | 2019-01-29 | Nugen Technologies, Inc. | Molecular tag attachment and transfer |
US11725232B2 (en) | 2016-10-31 | 2023-08-15 | The Hong Kong University Of Science And Technology | Compositions, methods and kits for detection of genetic variants for alzheimer's disease |
EA201991262A1 (en) | 2016-12-16 | 2020-04-07 | Твист Байосайенс Корпорейшн | LIBRARIES OF OPTIONS OF IMMUNOLOGICAL SYNAPSIS AND THEIR SYNTHESIS |
WO2018114706A1 (en) * | 2016-12-20 | 2018-06-28 | F. Hoffmann-La Roche Ag | Single stranded circular dna libraries for circular consensus sequencing |
IL267836B2 (en) | 2017-01-04 | 2023-09-01 | Complete Genomics Inc | Stepwise sequencing by non-labeled reversible terminators or natural nucleotides |
GB201704754D0 (en) | 2017-01-05 | 2017-05-10 | Illumina Inc | Kinetic exclusion amplification of nucleic acid libraries |
WO2018132916A1 (en) | 2017-01-20 | 2018-07-26 | Genomedx Biosciences, Inc. | Molecular subtyping, prognosis, and treatment of bladder cancer |
EP3589752B1 (en) | 2017-01-26 | 2021-05-19 | QIAGEN GmbH | Method for generating a sequencing library |
US10240205B2 (en) | 2017-02-03 | 2019-03-26 | Population Bio, Inc. | Methods for assessing risk of developing a viral disease using a genetic test |
CA3054303A1 (en) | 2017-02-22 | 2018-08-30 | Twist Bioscience Corporation | Nucleic acid based data storage |
CA3055925A1 (en) | 2017-03-09 | 2018-09-13 | Decipher Biosciences, Inc. | Subtyping prostate cancer to predict response to hormone therapy |
CA3056388A1 (en) | 2017-03-15 | 2018-09-20 | Twist Bioscience Corporation | Variant libraries of the immunological synapse and synthesis thereof |
US11584958B2 (en) | 2017-03-31 | 2023-02-21 | Grail, Llc | Library preparation and use thereof for sequencing based error correction and/or variant identification |
WO2018191563A1 (en) | 2017-04-12 | 2018-10-18 | Karius, Inc. | Sample preparation methods, systems and compositions |
EP3612646A1 (en) | 2017-04-18 | 2020-02-26 | Dovetail Genomics, LLC | Nucleic acid characteristics as guides for sequence assembly |
US11078542B2 (en) | 2017-05-12 | 2021-08-03 | Decipher Biosciences, Inc. | Genetic signatures to predict prostate cancer metastasis and identify tumor aggressiveness |
US20200165662A1 (en) * | 2017-05-12 | 2020-05-28 | Seoul National University R&Db Foundation | Method and apparatus for capturing high-purity nucleotides |
WO2018231864A1 (en) | 2017-06-12 | 2018-12-20 | Twist Bioscience Corporation | Methods for seamless nucleic acid assembly |
KR20240013290A (en) | 2017-06-12 | 2024-01-30 | 트위스트 바이오사이언스 코포레이션 | Methods for seamless nucleic acid assembly |
GB2578038B (en) | 2017-06-16 | 2022-11-23 | Life Technologies Corp | Control nucleic acids, and compositions, kits, and uses thereof |
CA3068273A1 (en) | 2017-06-21 | 2018-12-27 | Bluedot Llc | Systems and methods for identification of nucleic acids in a sample |
US11217329B1 (en) | 2017-06-23 | 2022-01-04 | Veracyte, Inc. | Methods and systems for determining biological sample integrity |
KR102480894B1 (en) | 2017-08-01 | 2022-12-23 | 일루미나, 인코포레이티드 | Hydrogel beads for nucleotide sequencing |
WO2019038594A2 (en) | 2017-08-21 | 2019-02-28 | Biolumic Limited | High growth and high hardiness transgenic plants |
GB2581620A (en) | 2017-09-11 | 2020-08-26 | Twist Bioscience Corp | GPCR binding proteins and synthesis thereof |
WO2019060716A1 (en) | 2017-09-25 | 2019-03-28 | Freenome Holdings, Inc. | Methods and systems for sample extraction |
CN111565834B (en) | 2017-10-20 | 2022-08-26 | 特韦斯特生物科学公司 | Heated nanopores for polynucleotide synthesis |
US11099202B2 (en) | 2017-10-20 | 2021-08-24 | Tecan Genomics, Inc. | Reagent delivery system |
WO2019086531A1 (en) * | 2017-11-03 | 2019-05-09 | F. Hoffmann-La Roche Ag | Linear consensus sequencing |
JP6849829B2 (en) | 2017-12-26 | 2021-03-31 | イラミーナ インコーポレーテッド | Sensor system |
EP3735459A4 (en) | 2018-01-04 | 2021-10-06 | Twist Bioscience Corporation | Dna-based digital information storage |
CA3090102A1 (en) | 2018-01-31 | 2019-08-08 | Dovetail Genomics, Llc | Sample prep for dna linkage recovery |
CN111094589A (en) | 2018-02-13 | 2020-05-01 | 伊鲁米纳公司 | DNA sequencing Using hydrogel beads |
CA3082601A1 (en) | 2018-03-16 | 2019-09-19 | Karius, Inc. | Sample series to differentiate target nucleic acids from contaminant nucleic acids |
EP3553182A1 (en) | 2018-04-11 | 2019-10-16 | Université de Bourgogne | Detection method of somatic genetic anomalies, combination of capture probes and kit of detection |
RU2750567C2 (en) | 2018-04-20 | 2021-06-29 | Иллумина, Инк. | Methods for encapsulating single cells, encapsulated cells, and methods of application thereof |
CN108765247B (en) * | 2018-05-15 | 2023-01-10 | 腾讯科技(深圳)有限公司 | Image processing method, device, storage medium and equipment |
CA3100739A1 (en) | 2018-05-18 | 2019-11-21 | Twist Bioscience Corporation | Polynucleotides, reagents, and methods for nucleic acid hybridization |
US10801064B2 (en) | 2018-05-31 | 2020-10-13 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
US11814750B2 (en) | 2018-05-31 | 2023-11-14 | Personalis, Inc. | Compositions, methods and systems for processing or analyzing multi-species nucleic acid samples |
WO2019238939A1 (en) | 2018-06-15 | 2019-12-19 | F. Hoffmann-La Roche Ag | A system for identification of antigens recognized by t cell receptors expressed on tumor infiltrating lymphocytes |
EP4177356A1 (en) | 2018-08-08 | 2023-05-10 | PML Screening, LLC | Methods for assessing risk of developing a viral disease using a genetic test |
WO2020047010A2 (en) | 2018-08-28 | 2020-03-05 | 10X Genomics, Inc. | Increasing spatial array resolution |
US11519033B2 (en) | 2018-08-28 | 2022-12-06 | 10X Genomics, Inc. | Method for transposase-mediated spatial tagging and analyzing genomic DNA in a biological sample |
US20210317524A1 (en) | 2018-08-28 | 2021-10-14 | 10X Genomics, Inc. | Resolving spatial arrays |
BR112021005976A2 (en) | 2018-10-26 | 2021-06-29 | Illumina, Inc. | modulation of polymer microspheres for DNA processing |
US11104888B2 (en) | 2018-10-31 | 2021-08-31 | Illumina, Inc. | Polymerases, compositions, and methods of use |
EP4293126A3 (en) | 2018-11-30 | 2024-01-17 | Illumina, Inc. | Analysis of multiple analytes using a single assay |
WO2020117968A2 (en) | 2018-12-05 | 2020-06-11 | Illumina, Inc. | Polymerases, compositions, and methods of use |
AU2019391274A1 (en) | 2018-12-05 | 2021-01-07 | Illumina Cambridge Limited | Methods and compositions for cluster generation by bridge amplification |
US20220162667A1 (en) | 2018-12-07 | 2022-05-26 | Octant, Inc. | Systems for protein-protein interaction screening |
WO2020123319A2 (en) | 2018-12-10 | 2020-06-18 | 10X Genomics, Inc. | Methods of using master / copy arrays for spatial detection |
AU2019411272A1 (en) | 2018-12-18 | 2021-01-07 | Illumina Cambridge Limited | Methods and compositions for paired end sequencing using a single surface primer |
US20200208214A1 (en) | 2018-12-19 | 2020-07-02 | Illumina, Inc. | Methods for improving polynucleotide cluster clonality |
US11649485B2 (en) | 2019-01-06 | 2023-05-16 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
US11926867B2 (en) | 2019-01-06 | 2024-03-12 | 10X Genomics, Inc. | Generating capture probes for spatial analysis |
KR20210144698A (en) | 2019-02-26 | 2021-11-30 | 트위스트 바이오사이언스 코포레이션 | Variant Nucleic Acid Libraries for Antibody Optimization |
EP3930753A4 (en) | 2019-02-26 | 2023-03-29 | Twist Bioscience Corporation | Variant nucleic acid libraries for glp1 receptor |
EP3931354A1 (en) | 2019-02-28 | 2022-01-05 | 10X Genomics, Inc. | Profiling of biological analytes with spatially barcoded oligonucleotide arrays |
WO2020190509A1 (en) | 2019-03-15 | 2020-09-24 | 10X Genomics, Inc. | Methods for using spatial arrays for single cell sequencing |
EP3887542A1 (en) | 2019-03-22 | 2021-10-06 | 10X Genomics, Inc. | Three-dimensional spatial analysis |
KR20220015443A (en) | 2019-05-28 | 2022-02-08 | 옥탄트, 인크. | enterprise relay system |
EP3976820A1 (en) | 2019-05-30 | 2022-04-06 | 10X Genomics, Inc. | Methods of detecting spatial heterogeneity of a biological sample |
CN114729342A (en) | 2019-06-21 | 2022-07-08 | 特韦斯特生物科学公司 | Barcode-based nucleic acid sequence assembly |
CA3125241A1 (en) | 2019-07-12 | 2021-01-21 | Illumina Cambridge Limited | Compositions and methods for preparing nucleic acid sequencing libraries using crispr/cas9 immobilized on a solid support |
US11287422B2 (en) | 2019-09-23 | 2022-03-29 | Element Biosciences, Inc. | Multivalent binding composition for nucleic acid analysis |
AU2020361681A1 (en) | 2019-10-10 | 2022-05-05 | 1859, Inc. | Methods and systems for microfluidic screening |
KR20220088632A (en) | 2019-10-25 | 2022-06-28 | 일루미나 케임브리지 리미티드 | Method of generating and sequencing an asymmetric adapter at the end of a polynucleotide template comprising a hairpin loop |
WO2021091611A1 (en) | 2019-11-08 | 2021-05-14 | 10X Genomics, Inc. | Spatially-tagged analyte capture agents for analyte multiplexing |
GB201919032D0 (en) | 2019-12-20 | 2020-02-05 | Cartana Ab | Method of detecting an analyte |
GB201919029D0 (en) | 2019-12-20 | 2020-02-05 | Cartana Ab | Method of detecting an analyte |
AU2020412459B2 (en) | 2019-12-23 | 2022-12-08 | Singular Genomics Systems, Inc. | Methods for long read sequencing |
US11155858B2 (en) | 2019-12-31 | 2021-10-26 | Singular Genomics Systems, Inc. | Polynucleotide barcodes for long read sequencing |
EP4107284A1 (en) | 2020-02-17 | 2022-12-28 | 10X Genomics, Inc. | In situ analysis of chromatin interaction |
WO2021168287A1 (en) | 2020-02-21 | 2021-08-26 | 10X Genomics, Inc. | Methods and compositions for integrated in situ spatial assay |
US11359238B2 (en) | 2020-03-06 | 2022-06-14 | Singular Genomics Systems, Inc. | Linked paired strand sequencing |
EP4153775A1 (en) | 2020-05-22 | 2023-03-29 | 10X Genomics, Inc. | Simultaneous spatio-temporal measurement of gene expression and cellular activity |
KR20230041725A (en) | 2020-08-06 | 2023-03-24 | 일루미나, 인코포레이티드 | Construction of RNA and DNA sequencing libraries using bead-linked transposomes |
KR20230051508A (en) | 2020-08-18 | 2023-04-18 | 일루미나, 인코포레이티드 | Sequence-specific targeted translocation and selection and sorting of nucleic acids |
US11200446B1 (en) | 2020-08-31 | 2021-12-14 | Element Biosciences, Inc. | Single-pass primary analysis |
KR20230069135A (en) | 2020-09-11 | 2023-05-18 | 일루미나 케임브리지 리미티드 | Methods for Enriching Target Sequences in Sequencing Libraries Using Hairpin Adapters |
US20220186300A1 (en) | 2020-12-11 | 2022-06-16 | 10X Genomics, Inc. | Methods and compositions for multimodal in situ analysis |
CN116848263A (en) | 2020-12-23 | 2023-10-03 | 10X基因组学有限公司 | Methods and compositions for analyte detection |
WO2022147139A1 (en) | 2020-12-30 | 2022-07-07 | 10X Genomics, Inc. | Methods and compositions for light-controlled surface patterning using a polymer |
US20220228201A1 (en) | 2020-12-30 | 2022-07-21 | 10X Genomics, Inc. | Molecular arrays and methods for generating and using the arrays |
US20220228210A1 (en) | 2020-12-30 | 2022-07-21 | 10X Genomics, Inc. | Molecular array generation using photoresist |
US20220235403A1 (en) | 2021-01-26 | 2022-07-28 | 10X Genomics, Inc. | Nucleic acid analog probes for in situ analysis |
CA3208854A1 (en) | 2021-02-04 | 2022-08-11 | Illumina, Inc. | Long indexed-linked read generation on transposome bound beads |
WO2022174054A1 (en) | 2021-02-13 | 2022-08-18 | The General Hospital Corporation | Methods and compositions for in situ macromolecule detection and uses thereof |
EP4301873A1 (en) | 2021-03-03 | 2024-01-10 | 10X Genomics, Inc. | Analyte detection in situ using nucleic acid origami |
CA3210451A1 (en) | 2021-03-22 | 2022-09-29 | Illumina Cambridge Limited | Methods for improving nucleic acid cluster clonality |
JP2024511766A (en) | 2021-03-29 | 2024-03-15 | イルミナ インコーポレイテッド | Improved library preparation method |
BR112023019894A2 (en) | 2021-03-29 | 2023-11-14 | Illumina Inc | COMPOSITIONS AND METHODS FOR ASSESSING DNA DAMAGE IN A LIBRARY AND NORMALIZING AMPLICON SIZE DISTORTION |
WO2022208171A1 (en) | 2021-03-31 | 2022-10-06 | UCL Business Ltd. | Methods for analyte detection |
IL307164A (en) | 2021-03-31 | 2023-11-01 | Illumina Inc | Methods of preparing directional tagmentation sequencing libraries using transposon-based technology with unique molecular identifiers for error correction |
EP4347877A1 (en) | 2021-06-01 | 2024-04-10 | 10X Genomics, Inc. | Methods and compositions for analyte detection and probe resolution |
WO2022256422A1 (en) | 2021-06-02 | 2022-12-08 | 10X Genomics, Inc. | Sample analysis using asymmetric circularizable probes |
US11427855B1 (en) | 2021-06-17 | 2022-08-30 | Element Biosciences, Inc. | Compositions and methods for pairwise sequencing |
US11859241B2 (en) | 2021-06-17 | 2024-01-02 | Element Biosciences, Inc. | Compositions and methods for pairwise sequencing |
WO2022266462A2 (en) | 2021-06-18 | 2022-12-22 | Element Biosciences, Inc. | Engineered polymerases |
WO2023283442A1 (en) | 2021-07-09 | 2023-01-12 | 10X Genomics, Inc. | Methods for detecting analytes using sparse labelling |
US20230057571A1 (en) | 2021-08-03 | 2023-02-23 | 10X Genomics, Inc. | Nucleic acid concatemers and methods for stabilizing and/or compacting the same |
US20230047225A1 (en) | 2021-08-14 | 2023-02-16 | Illumina, Inc. | Polymerases, compositions, and methods of use |
WO2023023484A1 (en) | 2021-08-16 | 2023-02-23 | 10X Genomics, Inc. | Probes comprising a split barcode region and methods of use |
WO2023102313A1 (en) | 2021-11-30 | 2023-06-08 | 10X Genomics, Inc. | Systems and methods for identifying regions of aneuploidy in a tissue |
WO2023108139A2 (en) | 2021-12-10 | 2023-06-15 | 10X Genomics, Inc. | Multi-resolution in situ decoding |
WO2023114203A1 (en) | 2021-12-13 | 2023-06-22 | Cornell University | Genotyping of targeted loci with single-cell chromatin accessibility |
AU2022424380A1 (en) | 2021-12-29 | 2024-01-18 | Illumina, Inc. | Methods of nucleic acid sequencing using surface-bound primers |
US20230279475A1 (en) | 2022-01-21 | 2023-09-07 | 10X Genomics, Inc. | Multiple readout signals for analyzing a sample |
WO2023159028A1 (en) | 2022-02-15 | 2023-08-24 | 10X Genomics, Inc. | Systems and methods for spatial analysis of analytes using fiducial alignment |
WO2023172915A1 (en) | 2022-03-08 | 2023-09-14 | 10X Genomics, Inc. | In situ code design methods for minimizing optical crowding |
WO2023192302A1 (en) | 2022-03-29 | 2023-10-05 | 10X Genomics, Inc. | Spectral unmixing combined with decoding for super-multiplexed in situ analysis |
EP4253550A1 (en) | 2022-04-01 | 2023-10-04 | GenCC GmbH 6 Co. KG | Method for the manufacture of a viral system, a vector system or any transport system for cancer-specific crispr complexes |
WO2023196526A1 (en) | 2022-04-06 | 2023-10-12 | 10X Genomics, Inc. | Methods for multiplex cell analysis |
US20240035071A1 (en) | 2022-06-17 | 2024-02-01 | 10X Genomics, Inc. | Catalytic de-crosslinking of samples for in situ analysis |
WO2024006797A1 (en) | 2022-06-29 | 2024-01-04 | 10X Genomics, Inc. | Methods and compositions for refining feature boundaries in molecular arrays |
WO2024006816A1 (en) | 2022-06-29 | 2024-01-04 | 10X Genomics, Inc. | Compositions and methods for oligonucleotide inversion on arrays |
US20240076721A1 (en) | 2022-06-29 | 2024-03-07 | 10X Genomics, Inc. | Method of generating arrays using microfluidics and photolithography |
WO2024006798A1 (en) | 2022-06-29 | 2024-01-04 | 10X Genomics, Inc. | High definition molecular array feature generation using photoresist |
WO2024006799A1 (en) | 2022-06-29 | 2024-01-04 | 10X Genomics, Inc. | Covalent attachment of splint oligonucleotides for molecular array generation using ligation |
US20240002932A1 (en) | 2022-06-29 | 2024-01-04 | 10X Genomics, Inc. | Click chemistry-based dna photo-ligation for manufacturing of high-resolution dna arrays |
WO2024006826A1 (en) | 2022-06-29 | 2024-01-04 | 10X Genomics, Inc. | Compositions and methods for generating molecular arrays using oligonucleotide printing and photolithography |
US20240084359A1 (en) | 2022-06-29 | 2024-03-14 | 10X Genomics, Inc. | Methods and compositions for patterned molecular array generation by directed bead delivery |
US20240060127A1 (en) | 2022-06-29 | 2024-02-22 | 10X Genomics, Inc. | Methods and systems for light-controlled surface patterning using photomasks |
WO2024068971A1 (en) | 2022-09-30 | 2024-04-04 | Illumina, Inc. | Polymerases, compositions, and methods of use |
Family Cites Families (131)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3010971A1 (en) | 1980-03-21 | 1981-10-08 | Siemens AG, 1000 Berlin und 8000 München | METHOD FOR PRODUCING AN OPTICAL 4-DOOR COUPLER |
US5821058A (en) | 1984-01-16 | 1998-10-13 | California Institute Of Technology | Automated DNA sequencing technique |
US5171534A (en) | 1984-01-16 | 1992-12-15 | California Institute Of Technology | Automated DNA sequencing technique |
US4965188A (en) | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) * | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
US5354825A (en) | 1985-04-08 | 1994-10-11 | Klainer Stanley M | Surface-bound fluorescent polymers and related methods of synthesis and use |
US4863849A (en) | 1985-07-18 | 1989-09-05 | New York Medical College | Automatable process for sequencing nucleotide |
US4811218A (en) | 1986-06-02 | 1989-03-07 | Applied Biosystems, Inc. | Real time scanning electrophoresis apparatus for DNA sequencing |
US5143853A (en) | 1986-06-25 | 1992-09-01 | Trustees Of Tufts College | Absorbance modulated fluorescence detection methods and sensors |
US4822746A (en) | 1986-06-25 | 1989-04-18 | Trustees Of Tufts College | Radiative and non-radiative energy transfer and absorbance modulated fluorescence detection methods and sensors |
US5114864A (en) | 1986-06-25 | 1992-05-19 | Trustees Of Tufts College | Fiber optic sensors, apparatus, and detection methods using fluid erodible controlled release polymers for delivery of reagent formulations |
US5254477A (en) | 1986-06-25 | 1993-10-19 | Trustees Of Tufts College | Flourescence intramolecular energy transfer conjugate compositions and detection methods |
US5252494A (en) | 1986-06-25 | 1993-10-12 | Trustees Of Tufts College | Fiber optic sensors, apparatus, and detection methods using controlled release polymers and reagent formulations held within a polymeric reaction matrix |
US5525464A (en) | 1987-04-01 | 1996-06-11 | Hyseq, Inc. | Method of sequencing by hybridization of oligonucleotide probes |
SE8801070D0 (en) | 1988-03-23 | 1988-03-23 | Pharmacia Ab | METHOD FOR IMMOBILIZING A DNA SEQUENCE ON A SOLID SUPPORT |
US4971903A (en) | 1988-03-25 | 1990-11-20 | Edward Hyman | Pyrophosphate-based method and apparatus for sequencing nucleic acids |
US6054270A (en) | 1988-05-03 | 2000-04-25 | Oxford Gene Technology Limited | Analying polynucleotide sequences |
US5700637A (en) | 1988-05-03 | 1997-12-23 | Isis Innovation Limited | Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays |
GB8822228D0 (en) | 1988-09-21 | 1988-10-26 | Southern E M | Support-bound oligonucleotides |
US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
US5143854A (en) | 1989-06-07 | 1992-09-01 | Affymax Technologies N.V. | Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof |
US6040138A (en) | 1995-09-15 | 2000-03-21 | Affymetrix, Inc. | Expression monitoring by hybridization to high density oligonucleotide arrays |
US5800992A (en) | 1989-06-07 | 1998-09-01 | Fodor; Stephen P.A. | Method of detecting nucleic acids |
US5871928A (en) | 1989-06-07 | 1999-02-16 | Fodor; Stephen P. A. | Methods for nucleic acid analysis |
US5302509A (en) | 1989-08-14 | 1994-04-12 | Beckman Instruments, Inc. | Method for sequencing polynucleotides |
US5545522A (en) | 1989-09-22 | 1996-08-13 | Van Gelder; Russell N. | Process for amplifying a target polynucleotide sequence using a single primer-promoter complex |
US5250264A (en) | 1991-01-25 | 1993-10-05 | Trustees Of Tufts College | Method of making imaging fiber optic sensors to concurrently detect multiple analytes of interest in a fluid sample |
US5244636A (en) | 1991-01-25 | 1993-09-14 | Trustees Of Tufts College | Imaging fiber optic array sensors, apparatus, and methods for concurrently detecting multiple analytes of interest in a fluid sample |
US5244813A (en) | 1991-01-25 | 1993-09-14 | Trustees Of Tufts College | Fiber optic sensor, apparatus, and methods for detecting an organic analyte in a fluid or vapor sample |
US5320814A (en) | 1991-01-25 | 1994-06-14 | Trustees Of Tufts College | Fiber optic array sensors, apparatus, and methods for concurrently visualizing and chemically detecting multiple analytes of interest in a fluid sample |
US5888819A (en) | 1991-03-05 | 1999-03-30 | Molecular Tool, Inc. | Method for determining nucleotide identity through primer extension |
US5114984A (en) | 1991-04-26 | 1992-05-19 | Olin Corporation | Process for producing an antimicrobially effective polyurethane |
US5605662A (en) * | 1993-11-01 | 1997-02-25 | Nanogen, Inc. | Active programmable electronic devices for molecular biological analysis and diagnostics |
DE69233331T3 (en) | 1991-11-22 | 2007-08-30 | Affymetrix, Inc., Santa Clara | Combinatorial Polymersynthesis Strategies |
US5445971A (en) | 1992-03-20 | 1995-08-29 | Abbott Laboratories | Magnetically assisted binding assays using magnetically labeled binding members |
US5587128A (en) * | 1992-05-01 | 1996-12-24 | The Trustees Of The University Of Pennsylvania | Mesoscale polynucleotide amplification devices |
GB9210176D0 (en) | 1992-05-12 | 1992-06-24 | Cemu Bioteknik Ab | Chemical method |
US6114114A (en) | 1992-07-17 | 2000-09-05 | Incyte Pharmaceuticals, Inc. | Comparative gene transcript analysis |
US5298741A (en) | 1993-01-13 | 1994-03-29 | Trustees Of Tufts College | Thin film fiber optic sensor array and apparatus for concurrent viewing and chemical sensing of a sample |
US5714320A (en) | 1993-04-15 | 1998-02-03 | University Of Rochester | Rolling circle synthesis of oligonucleotides and amplification of select randomized circular oligonucleotides |
US5861242A (en) | 1993-06-25 | 1999-01-19 | Affymetrix, Inc. | Array of nucleic acid probes on biological chips for diagnosis of HIV and methods of using the same |
US6027880A (en) | 1995-08-02 | 2000-02-22 | Affymetrix, Inc. | Arrays of nucleic acid probes and methods of using the same for detecting cystic fibrosis |
US5837832A (en) | 1993-06-25 | 1998-11-17 | Affymetrix, Inc. | Arrays of nucleic acid probes on biological chips |
GB9315847D0 (en) | 1993-07-30 | 1993-09-15 | Isis Innovation | Tag reagent and assay method |
US5482845A (en) | 1993-09-24 | 1996-01-09 | The Trustees Of Columbia University In The City Of New York | Method for construction of normalized cDNA libraries |
US7375198B2 (en) * | 1993-10-26 | 2008-05-20 | Affymetrix, Inc. | Modified nucleic acid probes |
US6156501A (en) | 1993-10-26 | 2000-12-05 | Affymetrix, Inc. | Arrays of modified nucleic acid probes and methods of use |
US5429807A (en) | 1993-10-28 | 1995-07-04 | Beckman Instruments, Inc. | Method and apparatus for creating biopolymer arrays on a solid support surface |
GB9401833D0 (en) | 1994-02-01 | 1994-03-30 | Isis Innovation | Method for discovering ligands |
US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
US5834252A (en) | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
JP2556293B2 (en) * | 1994-06-09 | 1996-11-20 | 日本電気株式会社 | MOS OTA |
US5512490A (en) | 1994-08-11 | 1996-04-30 | Trustees Of Tufts College | Optical sensor, optical sensing apparatus, and methods for detecting an analyte of interest using spectral recognition patterns |
US5604097A (en) | 1994-10-13 | 1997-02-18 | Spectragen, Inc. | Methods for sorting polynucleotides using oligonucleotide tags |
US6013445A (en) | 1996-06-06 | 2000-01-11 | Lynx Therapeutics, Inc. | Massively parallel signature sequencing by ligation of encoded adaptors |
US5795716A (en) | 1994-10-21 | 1998-08-18 | Chee; Mark S. | Computer-aided visualization and analysis system for sequence evaluation |
US5919673A (en) | 1995-03-22 | 1999-07-06 | The Scripps Research Institute | One-pot enzymatic sulfation process using 3'-phosphoadenosine-5'-phosphosulfate and recycled phosphorylated adenosine intermediates |
GB9507238D0 (en) * | 1995-04-07 | 1995-05-31 | Isis Innovation | Detecting dna sequence variations |
US5750341A (en) | 1995-04-17 | 1998-05-12 | Lynx Therapeutics, Inc. | DNA sequencing by parallel oligonucleotide extensions |
US5648245A (en) | 1995-05-09 | 1997-07-15 | Carnegie Institution Of Washington | Method for constructing an oligonucleotide concatamer library by rolling circle replication |
US5690894A (en) | 1995-05-23 | 1997-11-25 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
US5728529A (en) | 1995-06-23 | 1998-03-17 | Baylor College Of Medicine | Alternative dye-labeled ribonucleotides, deoxyribonucleotides, and dideoxyribonucleotides for automated DNA analysis |
US6200737B1 (en) | 1995-08-24 | 2001-03-13 | Trustees Of Tufts College | Photodeposition method for fabricating a three-dimensional, patterned polymer microstructure |
US5843655A (en) * | 1995-09-18 | 1998-12-01 | Affymetrix, Inc. | Methods for testing oligonucleotide arrays |
US5871697A (en) | 1995-10-24 | 1999-02-16 | Curagen Corporation | Method and apparatus for identifying, classifying, or quantifying DNA sequences in a sample without sequencing |
US5780231A (en) | 1995-11-17 | 1998-07-14 | Lynx Therapeutics, Inc. | DNA extension and analysis with rolling primers |
US5962228A (en) | 1995-11-17 | 1999-10-05 | Lynx Therapeutics, Inc. | DNA extension and analysis with rolling primers |
US5854033A (en) | 1995-11-21 | 1998-12-29 | Yale University | Rolling circle replication reporter systems |
US6143495A (en) * | 1995-11-21 | 2000-11-07 | Yale University | Unimolecular segment amplification and sequencing |
US5633972A (en) | 1995-11-29 | 1997-05-27 | Trustees Of Tufts College | Superresolution imaging fiber for subwavelength light energy generation and near-field optical microscopy |
US5814524A (en) | 1995-12-14 | 1998-09-29 | Trustees Of Tufts College | Optical sensor apparatus for far-field viewing and making optical analytical measurements at remote locations |
GB9526352D0 (en) * | 1995-12-22 | 1996-02-21 | Smithkline Beecham Plc | Novel compounds |
EP0880598A4 (en) * | 1996-01-23 | 2005-02-23 | Affymetrix Inc | Nucleic acid analysis techniques |
US5837196A (en) * | 1996-01-26 | 1998-11-17 | The Regents Of The University Of California | High density array fabrication and readout method for a fiber optic biosensor |
US5851772A (en) | 1996-01-29 | 1998-12-22 | University Of Chicago | Microchip method for the enrichment of specific DNA sequences |
US6228575B1 (en) | 1996-02-08 | 2001-05-08 | Affymetrix, Inc. | Chip-based species identification and phenotypic characterization of microorganisms |
US6013440A (en) * | 1996-03-11 | 2000-01-11 | Affymetrix, Inc. | Nucleic acid affinity columns |
US5846727A (en) | 1996-06-06 | 1998-12-08 | Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College | Microsystem for rapid DNA sequencing |
US5846721A (en) | 1996-09-19 | 1998-12-08 | The Trustees Of Columbia University In The City Of New York | Efficient and simpler method to construct normalized cDNA libraries with improved representations of full-length cDNAs |
GB9620209D0 (en) | 1996-09-27 | 1996-11-13 | Cemu Bioteknik Ab | Method of sequencing DNA |
US5856104A (en) | 1996-10-28 | 1999-01-05 | Affymetrix, Inc. | Polymorphisms in the glucose-6 phosphate dehydrogenase locus |
US5900481A (en) | 1996-11-06 | 1999-05-04 | Sequenom, Inc. | Bead linkers for immobilizing nucleic acids to solid supports |
US6133436A (en) | 1996-11-06 | 2000-10-17 | Sequenom, Inc. | Beads bound to a solid support and to nucleic acids |
US6887665B2 (en) * | 1996-11-14 | 2005-05-03 | Affymetrix, Inc. | Methods of array synthesis |
US6519583B1 (en) * | 1997-05-15 | 2003-02-11 | Incyte Pharmaceuticals, Inc. | Graphical viewer for biomolecular sequence data |
GB9626815D0 (en) | 1996-12-23 | 1997-02-12 | Cemu Bioteknik Ab | Method of sequencing DNA |
WO1998033939A1 (en) | 1997-01-31 | 1998-08-06 | Hitachi, Ltd. | Method for determining nucleic acid base sequence and apparatus therefor |
DE69825601T2 (en) * | 1997-02-12 | 2005-04-28 | Chan, Eugene Y, Brookline | METHOD FOR THE ANALYSIS OF POLYMERS |
US6023540A (en) | 1997-03-14 | 2000-02-08 | Trustees Of Tufts College | Fiber optic sensor with encoded microspheres |
US20030027126A1 (en) * | 1997-03-14 | 2003-02-06 | Walt David R. | Methods for detecting target analytes and enzymatic reactions |
US6327410B1 (en) * | 1997-03-14 | 2001-12-04 | The Trustees Of Tufts College | Target analyte sensors utilizing Microspheres |
WO1998041657A1 (en) * | 1997-03-20 | 1998-09-24 | Affymetrix, Inc. | Iterative resequencing |
US6406845B1 (en) * | 1997-05-05 | 2002-06-18 | Trustees Of Tuft College | Fiber optic biosensor for selectively detecting oligonucleotide species in a mixed fluid sample |
EP1009857B1 (en) * | 1997-06-13 | 2006-03-08 | Affymetrix, Inc. (a Delaware Corporation) | Method to detect gene polymorphisms and monitor allelic expression employing a probe array |
US6503711B1 (en) * | 1997-06-18 | 2003-01-07 | Ulrich J. Krull | Nucleic acid biosensor diagnostics |
US20010006630A1 (en) * | 1997-09-02 | 2001-07-05 | Oron Yacoby-Zeevi | Introducing a biological material into a patient |
US6036597A (en) * | 1998-02-11 | 2000-03-14 | Agco Corporation | Combine harvester rotor load control |
US6013449A (en) | 1997-11-26 | 2000-01-11 | The United States Of America As Represented By The Department Of Health And Human Services | Probe-based analysis of heterozygous mutations using two-color labelling |
US6232066B1 (en) * | 1997-12-19 | 2001-05-15 | Neogen, Inc. | High throughput assay system |
DE69822206T2 (en) * | 1997-12-19 | 2005-02-17 | Affymetrix, Inc., Santa Clara | KNOWLEDGE OF GENOME RESEARCH FOR THE SEARCH FOR NOVEL ACTIVE SUBSTANCES |
US6050719A (en) * | 1998-01-30 | 2000-04-18 | Affymetrix, Inc. | Rotational mixing method using a cartridge having a narrow interior |
US5882874A (en) | 1998-02-27 | 1999-03-16 | The Trustees Of Columbia University In The City Of New York | Reciprocal subtraction differential display |
US6210910B1 (en) * | 1998-03-02 | 2001-04-03 | Trustees Of Tufts College | Optical fiber biosensor array comprising cell populations confined to microcavities |
US6263286B1 (en) | 1998-08-13 | 2001-07-17 | U.S. Genomics, Inc. | Methods of analyzing polymers using a spatial network of fluorophores and fluorescence resonance energy transfer |
US6210896B1 (en) | 1998-08-13 | 2001-04-03 | Us Genomics | Molecular motors |
US6306643B1 (en) | 1998-08-24 | 2001-10-23 | Affymetrix, Inc. | Methods of using an array of pooled probes in genetic analysis |
US20020012913A1 (en) * | 1998-09-15 | 2002-01-31 | Kevin L. Gunderson | Nucleic acid analysis using complete n-mer arrays |
US6203989B1 (en) * | 1998-09-30 | 2001-03-20 | Affymetrix, Inc. | Methods and compositions for amplifying detectable signals in specific binding assays |
US6285807B1 (en) | 1998-11-16 | 2001-09-04 | Trustees Of Tufts College | Fiber optic sensor for long-term analyte measurements in fluids |
US6255476B1 (en) | 1999-02-22 | 2001-07-03 | Pe Corporation (Ny) | Methods and compositions for synthesis of labelled oligonucleotides and analogs on solid-supports |
US6225061B1 (en) | 1999-03-10 | 2001-05-01 | Sequenom, Inc. | Systems and methods for performing reactions in an unsealed environment |
US6355431B1 (en) * | 1999-04-20 | 2002-03-12 | Illumina, Inc. | Detection of nucleic acid amplification reactions using bead arrays |
US20030108867A1 (en) * | 1999-04-20 | 2003-06-12 | Chee Mark S | Nucleic acid sequencing using microsphere arrays |
US6221653B1 (en) | 1999-04-27 | 2001-04-24 | Agilent Technologies, Inc. | Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids |
US6544732B1 (en) * | 1999-05-20 | 2003-04-08 | Illumina, Inc. | Encoding and decoding of array sensors utilizing nanocrystals |
ATE338273T1 (en) * | 1999-05-20 | 2006-09-15 | Illumina Inc | DEVICE FOR HOLDING AND PRESENTING AT LEAST ONE MICRO SPHERE MATRIX FOR SOLUTIONS AND/OR OPTICAL IMAGING SYSTEMS |
US20020051971A1 (en) * | 1999-05-21 | 2002-05-02 | John R. Stuelpnagel | Use of microfluidic systems in the detection of target analytes using microsphere arrays |
US7244559B2 (en) * | 1999-09-16 | 2007-07-17 | 454 Life Sciences Corporation | Method of sequencing a nucleic acid |
US6274320B1 (en) * | 1999-09-16 | 2001-08-14 | Curagen Corporation | Method of sequencing a nucleic acid |
US7390459B2 (en) * | 1999-12-13 | 2008-06-24 | Illumina, Inc. | Oligonucleotide synthesizer |
ATE527053T1 (en) * | 1999-12-13 | 2011-10-15 | Illumina Inc | SYNTHESIS DEVICE FOR OLIGONUCLEOTIDES USING CENTRIFLY FORCE |
US7361488B2 (en) * | 2000-02-07 | 2008-04-22 | Illumina, Inc. | Nucleic acid detection methods using universal priming |
US20040121364A1 (en) * | 2000-02-07 | 2004-06-24 | Mark Chee | Multiplex nucleic acid reactions |
DE60136166D1 (en) * | 2000-02-07 | 2008-11-27 | Illumina Inc | NUCLEIC ACID PROOF METHOD WITH UNIVERSAL PRIMING |
JP4954415B2 (en) * | 2000-02-10 | 2012-06-13 | イルミナ インコーポレイテッド | Arrays of individual arrays as a substrate for simultaneous processing based on sample beads and methods for their manufacture |
AU2001238389B2 (en) * | 2000-02-16 | 2006-09-21 | Illumina, Inc. | Parallel genotyping of multiple patient samples |
US20030096239A1 (en) * | 2000-08-25 | 2003-05-22 | Kevin Gunderson | Probes and decoder oligonucleotides |
US6720007B2 (en) * | 2000-10-25 | 2004-04-13 | Tufts University | Polymeric microspheres |
US20040018491A1 (en) * | 2000-10-26 | 2004-01-29 | Kevin Gunderson | Detection of nucleic acid reactions on bead arrays |
US7078168B2 (en) * | 2001-02-27 | 2006-07-18 | Biotage Ab | Method for determining allele frequencies |
-
2001
- 2001-03-21 US US09/814,338 patent/US7244559B2/en not_active Expired - Fee Related
-
2002
- 2002-03-21 EP EP02715174A patent/EP1381693B1/en not_active Expired - Lifetime
- 2002-03-21 JP JP2002575327A patent/JP4354184B2/en not_active Expired - Fee Related
- 2002-03-21 CA CA2441603A patent/CA2441603C/en not_active Expired - Fee Related
- 2002-03-21 US US10/104,280 patent/US20030068629A1/en not_active Abandoned
- 2002-03-21 WO PCT/US2002/008700 patent/WO2002077287A1/en active Application Filing
- 2002-03-21 ES ES02715174T patent/ES2348435T3/en not_active Expired - Lifetime
- 2002-03-21 DE DE60236502T patent/DE60236502D1/en not_active Expired - Lifetime
- 2002-03-21 AT AT02715174T patent/ATE468915T1/en not_active IP Right Cessation
- 2002-03-21 AU AU2002247390A patent/AU2002247390B9/en not_active Ceased
- 2002-08-15 US US10/222,298 patent/US20070092872A1/en not_active Abandoned
- 2002-08-15 US US10/222,592 patent/US7335762B2/en not_active Expired - Fee Related
- 2002-11-19 US US10/299,180 patent/US7264929B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2002247390A1 (en) | 2002-10-08 |
US20030148344A1 (en) | 2003-08-07 |
CA2441603C (en) | 2012-01-10 |
US20030068629A1 (en) | 2003-04-10 |
JP4354184B2 (en) | 2009-10-28 |
EP1381693A4 (en) | 2005-12-21 |
WO2002077287A1 (en) | 2002-10-03 |
JP2005505748A (en) | 2005-02-24 |
ES2348435T3 (en) | 2010-12-07 |
AU2002247390B2 (en) | 2007-01-25 |
DE60236502D1 (en) | 2010-07-08 |
US20070092872A1 (en) | 2007-04-26 |
US7335762B2 (en) | 2008-02-26 |
US7264929B2 (en) | 2007-09-04 |
US20020012930A1 (en) | 2002-01-31 |
AU2002247390B9 (en) | 2007-03-22 |
US20030100102A1 (en) | 2003-05-29 |
ATE468915T1 (en) | 2010-06-15 |
EP1381693A1 (en) | 2004-01-21 |
EP1381693B1 (en) | 2010-05-26 |
US7244559B2 (en) | 2007-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2441603A1 (en) | Apparatus and method for sequencing a nucleic acid | |
US9040237B2 (en) | Sensor arrays and nucleic acid sequencing applications | |
US6750018B2 (en) | Method for detecting nucleic acid mutation by detecting chemiluminiscence generated with by-product of complementary strand extension reaction | |
CA2384510A1 (en) | Method of sequencing a nucleic acid | |
US8372585B2 (en) | Electronic sensing for nucleic acid sequencing | |
EP0820524B1 (en) | Detecting dna sequence variations | |
US20170335389A1 (en) | Sensor arrays and nucleic acid sequencing applications | |
US20090163366A1 (en) | Two-primer sequencing for high-throughput expression analysis | |
EP1498494A2 (en) | Method of nucleic acid sequencing | |
JP2008513782A5 (en) | ||
US20130344540A1 (en) | Methods for minimizing sequence specific bias | |
KR102189965B1 (en) | Orthogonal deblocking of nucleotides | |
EP2674492A1 (en) | Method for detecting nucleic acid | |
WO2002029085A2 (en) | Nucleotide detection method | |
US11332780B2 (en) | Simplified polynucleotide sequence detection method | |
KR20220062231A (en) | Methods and compositions for identifying ligands on arrays using indexes and barcodes | |
Li et al. | DNA microarray technology in microbial ecology studies-principle, applications and current limitations | |
US20110045485A1 (en) | Analytical method and kit | |
US20060263790A1 (en) | Methods for improving fidelity in a nucleic acid synthesis reaction | |
EP3663407B1 (en) | Nucleic acid sequencing method | |
RU2816708C2 (en) | Methods and compositions for determining ligands on matrices using indices and barcodes | |
WO2009086353A1 (en) | Improved two-primer sequencing for high-throughput expression analysis | |
US20060003360A1 (en) | Method for analyzing variation of nucleic acid and method for analyzing gene expression | |
JP2003135098A (en) | Method for testing gene | |
AU2001291513B2 (en) | Nucleotide detection method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20160321 |